BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, Wu GS, Licht JD, Weber BL, El-Deiry WS. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature. 1997;389:187-19. [PMID: 9296497 DOI: 10.1038/38291] [Cited by in Crossref: 356] [Cited by in F6Publishing: 371] [Article Influence: 14.2] [Reference Citation Analysis]
Number Citing Articles
1 Honrado E, Osorio A, Palacios J, Benitez J. Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 2006;25:5837-45. [PMID: 16998498 DOI: 10.1038/sj.onc.1209875] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 4.4] [Reference Citation Analysis]
2 Aiyar S, Sun JL, Li R. BRCA1: a locus-specific "liaison" in gene expression and genetic integrity. J Cell Biochem 2005;94:1103-11. [PMID: 15723343 DOI: 10.1002/jcb.20386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Yu X, Baer R. Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor. J Biol Chem. 2000;275:18541-18549. [PMID: 10764811 DOI: 10.1074/jbc.m909494199] [Cited by in Crossref: 111] [Cited by in F6Publishing: 67] [Article Influence: 5.0] [Reference Citation Analysis]
4 Wong K, Zhang J, Awasthi S, Sharma A, Rogers L, Matlock EF, Van Lint C, Karpova T, McNally J, Harrod R. Nerve growth factor receptor signaling induces histone acetyltransferase domain-dependent nuclear translocation of p300/CREB-binding protein-associated factor and hGCN5 acetyltransferases. J Biol Chem 2004;279:55667-74. [PMID: 15496412 DOI: 10.1074/jbc.M408174200] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
5 Lee W. Frequent Loss of BRCA1 Nuclear Expression in Young Women With Breast Cancer: An Immunohistochemical Study From an Area of Low Incidence but Early Onset: . Applied Immunohistochemistry & Molecular Morphology 2002;10:310-5. [DOI: 10.1097/00129039-200212000-00004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Zhang L, Wang D, Jiang W, Edwards D, Qiu W, Barroilhet LM, Rho JH, Jin L, Seethappan V, Vitonis A, Wang J, Mok SC, Crum C, Cramer DW, Ye B. Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium. Reprod Biol Endocrinol 2010;8:74. [PMID: 20576130 DOI: 10.1186/1477-7827-8-74] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
7 Wang Q, Zhang H, Guerrette S, Chen J, Mazurek A, Wilson T, Slupianek A, Skorski T, Fishel R, Greene MI. Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1. Oncogene 2001;20:4640-9. [PMID: 11498787 DOI: 10.1038/sj.onc.1204625] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
8 Park J, Oh Y, Yoo L, Jung MS, Song WJ, Lee SH, Seo H, Chung KC. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells. J Biol Chem 2010;285:31895-906. [PMID: 20696760 DOI: 10.1074/jbc.M110.147520] [Cited by in Crossref: 74] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
9 Somasundaram K, MacLachlan TK, Burns TF, Sgagias M, Cowan KH, Weber BL, el-Deiry WS. BRCA1 signals ARF-dependent stabilization and coactivation of p53. Oncogene 1999;18:6605-14. [PMID: 10597265 DOI: 10.1038/sj.onc.1203284] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 2.1] [Reference Citation Analysis]
10 McPherson JP, Lemmers B, Hirao A, Hakem A, Abraham J, Migon E, Matysiak-Zablocki E, Tamblyn L, Sanchez-Sweatman O, Khokha R, Squire J, Hande MP, Mak TW, Hakem R. Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev 2004;18:1144-53. [PMID: 15131084 DOI: 10.1101/gad.1192704] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 2.4] [Reference Citation Analysis]
11 Lee WS, Chen RJ, Wang YJ, Tseng H, Jeng JH, Lin SY, Liang YC, Chen CH, Lin CH, Lin JK. In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest. Int J Cancer. 2003;106:125-137. [PMID: 12794767 DOI: 10.1002/ijc.11194] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 2.5] [Reference Citation Analysis]
12 Sourvinos G, Spandidos DA. DecreasedBRCA1Expression Levels May Arrest the Cell Cycle through Activation ofp53Checkpoint in Human Sporadic Breast Tumors. Biochemical and Biophysical Research Communications 1998;245:75-80. [DOI: 10.1006/bbrc.1998.8379] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 2.5] [Reference Citation Analysis]
13 Ratanaphan A, Canyuk B. Host Cell Reactivation and Transcriptional Activation of Carboplatin-Modified BRCA1. Breast Cancer (Auckl) 2014;8:51-6. [PMID: 24678242 DOI: 10.4137/BCBCR.S14224] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Fitzgerald LD, Bailey CK, Brandt SJ, Thompson ME. BRCA1 accumulates in the nucleus in response to hypoxia and TRAIL and enhances TRAIL-induced apoptosis in breast cancer cells. FEBS J 2007;274:5137-46. [PMID: 17803681 DOI: 10.1111/j.1742-4658.2007.06033.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
15 Milutinovic S, Brown SE, Zhuang Q, Szyf M. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. J Biol Chem 2004;279:27915-27. [PMID: 15087453 DOI: 10.1074/jbc.M312823200] [Cited by in Crossref: 76] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
16 Hill DA, de la Serna IL, Veal TM, Imbalzano AN. BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2. J Cell Biochem 2004;91:987-98. [PMID: 15034933 DOI: 10.1002/jcb.20003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
17 Savage K, Harkin DP. BRCA1 and BRCA2: Role in the DNA Damage Response, Cancer Formation and Treatment. In: Khanna KK, Shiloh Y, editors. The DNA Damage Response: Implications on Cancer Formation and Treatment. Dordrecht: Springer Netherlands; 2009. pp. 415-43. [DOI: 10.1007/978-90-481-2561-6_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA, Holt JT. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J Biol Chem 1999;274:18808-12. [PMID: 10373498 DOI: 10.1074/jbc.274.26.18808] [Cited by in Crossref: 156] [Cited by in F6Publishing: 156] [Article Influence: 6.8] [Reference Citation Analysis]
19 Cozen W, Bernstein L, Wang F, Press MF, Mack TM. The risk of angiosarcoma following primary breast cancer. Br J Cancer 1999;81:532-6. [PMID: 10507781 DOI: 10.1038/sj.bjc.6690726] [Cited by in Crossref: 83] [Cited by in F6Publishing: 62] [Article Influence: 3.6] [Reference Citation Analysis]
20 Li D, Kang N, Ji J, Zhan Q. BRCA1 regulates transforming growth factor-β (TGF-β1) signaling through Gadd45a by enhancing the protein stability of Smad4. Mol Oncol 2015;9:1655-66. [PMID: 26022109 DOI: 10.1016/j.molonc.2015.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
21 Liu S, Bishop WR, Liu M. Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat. 2003;6:183-195. [PMID: 12962684 DOI: 10.1016/S1368-7646(03)00044-X] [Cited by in Crossref: 123] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
22 Zuo Z, Dean NM, Honkanen RE. Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest. J Biol Chem 1998;273:12250-8. [PMID: 9575175 DOI: 10.1074/jbc.273.20.12250] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 3.3] [Reference Citation Analysis]
23 Pickholtz I, Saadyan S, Keshet GI, Wang VS, Cohen R, Bouwman P, Jonkers J, Byers SW, Papa MZ, Yarden RI. Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and growth inhibition of breast cancer cells and cancer stem-like cells. Oncotarget. 2014;5:11827-11846. [PMID: 25460500 DOI: 10.18632/oncotarget.2582] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
24 Taneja P, Maglic D, Kai F, Zhu S, Kendig RD, Fry EA, Inoue K. Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. Clin Med Insights Oncol 2010;4:15-34. [PMID: 20567632 DOI: 10.4137/cmo.s4773] [Cited by in Crossref: 64] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
25 Fan S, Twu NF, Wang JA, Yuan RQ, Andres J, Goldberg ID, Rosen EM. Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation. Int J Cancer 1998;77:600-9. [PMID: 9679765 DOI: 10.1002/(sici)1097-0215(19980812)77:4<600::aid-ijc21>3.0.co;2-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
26 Fajas L, Paul C, Zugasti O, Le Cam L, Polanowska J, Fabbrizio E, Medema R, Vignais ML, Sardet C. pRB binds to and modulates the transrepressing activity of the E1A-regulated transcription factor p120E4F. Proc Natl Acad Sci U S A 2000;97:7738-43. [PMID: 10869426 DOI: 10.1073/pnas.130198397] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
27 Olopade OI, Fackenthal JD. BREAST CANCER GENETICS. Hematology/Oncology Clinics of North America 2000;14:705-25. [DOI: 10.1016/s0889-8588(05)70304-x] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
28 Deng C, Scott F. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene 2000;19:1059-64. [DOI: 10.1038/sj.onc.1203269] [Cited by in Crossref: 86] [Cited by in F6Publishing: 91] [Article Influence: 3.9] [Reference Citation Analysis]
29 Welcsh PL, Schubert EL, King M. Inherited breast cancer: an emerging picture. Clinical Genetics 1998;54:447-58. [DOI: 10.1111/j.1399-0004.1998.tb03764.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
30 Decesse JT, Medjkane S, Datto MB, Crémisi CE. RB regulates transcription of the p21/WAF1/CIP1 gene. Oncogene 2001;20:962-71. [PMID: 11314031 DOI: 10.1038/sj.onc.1204169] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.5] [Reference Citation Analysis]
31 Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace AJ, Zhan Q. BRCA1 activation of the GADD45 promoter. Oncogene 2000;19:4050-7. [DOI: 10.1038/sj.onc.1203759] [Cited by in Crossref: 58] [Cited by in F6Publishing: 70] [Article Influence: 2.6] [Reference Citation Analysis]
32 Venkitaraman AR. Functions of BRCA1 and BRCA2 in the biological response to DNA damage. Journal of Cell Science 2001;114:3591-8. [DOI: 10.1242/jcs.114.20.3591] [Cited by in Crossref: 55] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
33 Özer E, Sis B, Özen E, Sakizli M, Canda T, Sarioğlu S. BRCA1, C-erbB-2, and H-ras Gene Expressions in Young Women with Breast Cancer: An Immunohistochemical Study. Applied Immunohistochemistry & Molecular Morphology 2000;8:12-8. [DOI: 10.1097/00129039-200003000-00002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
34 Rosen EM, Fan S, Ma Y. BRCA1 regulation of transcription. Cancer Lett 2006;236:175-85. [PMID: 15975711 DOI: 10.1016/j.canlet.2005.04.037] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 3.3] [Reference Citation Analysis]
35 Kim J, Lee D, Gwan Hwang S, Hwang ES, Choe J. BRCA1 associates with human papillomavirus type 18 E2 and stimulates E2-dependent transcription. Biochem Biophys Res Commun 2003;305:1008-16. [PMID: 12767931 DOI: 10.1016/s0006-291x(03)00880-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
36 Liu F, Lee WH. CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression. Mol Cell Biol 2006;26:3124-34. [PMID: 16581787 DOI: 10.1128/MCB.26.8.3124-3134.2006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
37 Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. J Biol Chem. 2001;276:29116-29125. [PMID: 11384995 DOI: 10.1074/jbc.m104130200] [Cited by in Crossref: 124] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
38 Krum SA, Miranda GA, Lin C, Lane TF. BRCA1 Associates with Processive RNA Polymerase II. Journal of Biological Chemistry 2003;278:52012-20. [DOI: 10.1074/jbc.m308418200] [Cited by in Crossref: 49] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
39 Deng CX, Brodie SG. Roles of BRCA1 and its interacting proteins. Bioessays 2000;22:728-37. [PMID: 10918303 DOI: 10.1002/1521-1878(200008)22:8<728::AID-BIES6>3.0.CO;2-B] [Cited by in Crossref: 181] [Cited by in F6Publishing: 83] [Article Influence: 8.2] [Reference Citation Analysis]
40 McAllister KA, Wiseman RW. Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related? Breast Cancer Res 2002;4:54-7. [PMID: 11879563 DOI: 10.1186/bcr422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
41 Tong B, Grimes HL, Yang TY, Bear SE, Qin Z, Du K, El-Deiry WS, Tsichlis PN. The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation. Mol Cell Biol 1998;18:2462-73. [PMID: 9566867 DOI: 10.1128/MCB.18.5.2462] [Cited by in Crossref: 88] [Cited by in F6Publishing: 46] [Article Influence: 3.7] [Reference Citation Analysis]
42 Wu Q, Kirschmeier P, Hockenberry T, Yang TY, Brassard DL, Wang L, McClanahan T, Black S, Rizzi G, Musco ML. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells. J Biol Chem. 2002;277:36329-36337. [PMID: 12138103 DOI: 10.1074/jbc.m204962200] [Cited by in Crossref: 77] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
43 Hsu LC, White RL. BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci U S A 1998;95:12983-8. [PMID: 9789027 DOI: 10.1073/pnas.95.22.12983] [Cited by in Crossref: 200] [Cited by in F6Publishing: 215] [Article Influence: 8.3] [Reference Citation Analysis]
44 Rauh-adelmann C, Lau K, Sabeti N, Long JP, Mok SC, Ho S. Altered expression ofBRCA1,BRCA2, and a newly identifiedBRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines. Mol Carcinog 2000;28:236-46. [DOI: 10.1002/1098-2744(200008)28:4<236::aid-mc6>3.0.co;2-h] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
45 Deeds L, Teodorescu S, Chu M, Yu Q, Chen CY. A p53-independent G1 cell cycle checkpoint induced by the suppression of protein kinase C alpha and theta isoforms. J Biol Chem. 2003;278:39782-39793. [PMID: 12896972 DOI: 10.1074/jbc.m306854200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
46 Gartel AL, Tyner AL. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res. 1999;246:280-289. [PMID: 9925742 DOI: 10.1006/excr.1998.4319] [Cited by in Crossref: 478] [Cited by in F6Publishing: 464] [Article Influence: 20.8] [Reference Citation Analysis]
47 Shukla V, Coumoul X, Lahusen T, Wang RH, Xu X, Vassilopoulos A, Xiao C, Lee MH, Man YG, Ouchi M, Ouchi T, Deng CX. BRCA1 affects global DNA methylation through regulation of DNMT1. Cell Res 2010;20:1201-15. [PMID: 20820192 DOI: 10.1038/cr.2010.128] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
48 Tait DL, Obermiller PS, Holt JT. Preclinical Studies of a New Generation Retroviral Vector for Ovarian Cancer BRCA1 Gene Therapy. Gynecologic Oncology 2000;79:471-6. [DOI: 10.1006/gyno.2000.5969] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
49 Chen Y, Lee W, Chew HK. Emerging roles of BRCA1 in transcriptional regulation and DNA repair. J Cell Phys 1999;181:385-92. [DOI: 10.1002/(sici)1097-4652(199912)181:3<385::aid-jcp2>3.0.co;2-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
50 Fernández PL, Jares P, Rey MJ, Campo E, Cardesa A. Cell cycle regulators and their abnormalities in breast cancer. Mol Pathol. 1998;51:305-309. [PMID: 10193510 DOI: 10.1136/mp.51.6.305] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
51 Obermiller PS, Tait DL, Holt JT. Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies. Breast Cancer Res 2000;2:28-31. [PMID: 11250690 DOI: 10.1186/bcr26] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
52 Rodrigues FC, Kawasaki-oyama RS, Fo JF, Ukuyama ÉE, Antonio JR, Bozola AR, Romeiro JG, Rahal P, Tajara EH. Analysis of CDKN1A polymorphisms. Cancer Genetics and Cytogenetics 2003;142:92-8. [DOI: 10.1016/s0165-4608(02)00839-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
53 Werness BA, Eltabbakh GH. Familial Ovarian Cancer and Early Ovarian Cancer: Biologic, Pathologic, and Clinical Features: . International Journal of Gynecological Pathology 2001;20:48-63. [DOI: 10.1097/00004347-200101000-00005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
54 Torres M, Al-buhairi M, Alsbeih G. Induction of p53 and p21 proteins by gamma radiation in skin fibroblasts derived from breast cancer patients. International Journal of Radiation Oncology*Biology*Physics 2004;58:479-84. [DOI: 10.1016/j.ijrobp.2003.09.062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
55 Manu KA, Cao PHA, Chai TF, Casey PJ, Wang M. p21cip1/waf1 Coordinate Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress. Cancers (Basel) 2019;11:E1112. [PMID: 31382612 DOI: 10.3390/cancers11081112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
56 Chang S, Sharan SK. BRCA1 and microRNAs: emerging networks and potential therapeutic targets. Mol Cells 2012;34:425-32. [PMID: 22936386 DOI: 10.1007/s10059-012-0118-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
57 Schüchner S, Tembe V, Rodriguez JA, Henderson BR. Nuclear Targeting and Cell Cycle Regulatory Function of Human BARD1. Journal of Biological Chemistry 2005;280:8855-61. [DOI: 10.1074/jbc.m413741200] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
58 Blagosklonny MV, An WG, Melillo G, Nguyen P, Trepel JB, Neckers LM. Regulation of BRCA1 by protein degradation. Oncogene 1999;18:6460-8. [PMID: 10597248 DOI: 10.1038/sj.onc.1203068] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 1.9] [Reference Citation Analysis]
59 Ruffner H, Jiang W, Craig AG, Hunter T, Verma IM. BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol Cell Biol 1999;19:4843-54. [PMID: 10373534 DOI: 10.1128/MCB.19.7.4843] [Cited by in Crossref: 70] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
60 Moisan A, Larochelle C, Guillemette B, Gaudreau L. BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels. Mol Cell Biol 2004;24:6947-56. [PMID: 15282296 DOI: 10.1128/MCB.24.16.6947-6956.2004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
61 Horwitz AA, Sankaran S, Parvin JD. Direct stimulation of transcription initiation by BRCA1 requires both its amino and carboxyl termini. J Biol Chem 2006;281:8317-20. [PMID: 16473884 DOI: 10.1074/jbc.C500475200] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
62 Moussa RS, Park KC, Kovacevic Z, Richardson DR. Ironing out the role of the cyclin-dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity. Free Radic Biol Med 2019;133:276-94. [PMID: 29572098 DOI: 10.1016/j.freeradbiomed.2018.03.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
63 Welcsh PL, Owens KN, King MC. Insights into the functions of BRCA1 and BRCA2. Trends Genet 2000;16:69-74. [PMID: 10652533 DOI: 10.1016/s0168-9525(99)01930-7] [Cited by in Crossref: 213] [Cited by in F6Publishing: 65] [Article Influence: 9.7] [Reference Citation Analysis]
64 Williamson EA, Wolf I, O'Kelly J, Bose S, Tanosaki S, Koeffler HP. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). Oncogene 2006;25:1391-9. [PMID: 16331276 DOI: 10.1038/sj.onc.1209170] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
65 Gao X, Honn KV. Chapter 5 Molecular biology of prostate cancer. The Oncobiology of the Prostate. Elsevier; 1999. pp. 85-122. [DOI: 10.1016/s1569-254x(99)80006-5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
66 Abukhdeir AM, Park BH. P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 2008;10:e19. [PMID: 18590585 DOI: 10.1017/S1462399408000744] [Cited by in Crossref: 253] [Cited by in F6Publishing: 159] [Article Influence: 18.1] [Reference Citation Analysis]
67 Garcia V, Domínguez G, García JM, Silva J, Peña C, Silva JM, Carcereny E, Menendez J, España P, Bonilla F. Altered expression of the ZBRK1 gene in human breast carcinomas. J Pathol 2004;202:224-32. [PMID: 14743505 DOI: 10.1002/path.1513] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
68 Wu J, Lingrel JB. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene 2004;23:8088-96. [PMID: 15361832 DOI: 10.1038/sj.onc.1207996] [Cited by in Crossref: 87] [Cited by in F6Publishing: 87] [Article Influence: 4.8] [Reference Citation Analysis]
69 Fabbro M, Savage K, Hobson K, Deans AJ, Powell SN, McArthur GA, Khanna KK. BRCA1-BARD1 complexes are required for p53Ser-15 phosphorylation and a G1/S arrest following ionizing radiation-induced DNA damage. J Biol Chem. 2004;279:31251-31258. [PMID: 15159397 DOI: 10.1074/jbc.M405372200] [Cited by in Crossref: 94] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
70 Kim ST, Lim DS, Canman CE, Kastan MB. Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem. 1999;274:37538-37543. [PMID: 10608806 DOI: 10.1074/jbc.274.53.37538] [Cited by in Crossref: 510] [Cited by in F6Publishing: 509] [Article Influence: 23.2] [Reference Citation Analysis]
71 Shackelford RE, Kaufmann WK, Paules RS. Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ Health Perspect 1999;107 Suppl 1:5-24. [PMID: 10229703 DOI: 10.1289/ehp.99107s15] [Cited by in Crossref: 114] [Cited by in F6Publishing: 120] [Article Influence: 5.2] [Reference Citation Analysis]
72 Liu L, Guo X, Rao JN, Zou T, Marasa BS, Chen J, Greenspon J, Casero RA Jr, Wang JY. Polyamine-modulated c-Myc expression in normal intestinal epithelial cells regulates p21Cip1 transcription through a proximal promoter region. Biochem J 2006;398:257-67. [PMID: 16706751 DOI: 10.1042/BJ20060217] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
73 Irminger-Finger I, Soriano JV, Vaudan G, Montesano R, Sappino AP. In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells. J Cell Biol 1998;143:1329-39. [PMID: 9832560 DOI: 10.1083/jcb.143.5.1329] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 3.0] [Reference Citation Analysis]
74 Maor SB, Abramovitch S, Erdos MR, Brody LC, Werner H. BRCA1 Suppresses Insulin-like Growth Factor-I Receptor Promoter Activity: Potential Interaction between BRCA1 and Sp1. Molecular Genetics and Metabolism 2000;69:130-6. [DOI: 10.1006/mgme.1999.2958] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
75 Lee YH, Bedford MT, Stallcup MR. Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylation. Genes Dev 2011;25:176-88. [PMID: 21245169 DOI: 10.1101/gad.1975811] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
76 Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol Cell Biol. 2005;25:8097-8107. [PMID: 16135801 DOI: 10.1128/mcb.25.18.8097-8107.2005] [Cited by in Crossref: 126] [Cited by in F6Publishing: 68] [Article Influence: 7.4] [Reference Citation Analysis]
77 Williamson EA, Dadmanesh F, Koeffler HP. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1. Oncogene 2002;21:3199-206. [DOI: 10.1038/sj.onc.1205461] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 2.2] [Reference Citation Analysis]
78 Irminger-finger I, Siegel B, Leung W. The Functions of Breast Cancer Susceptibility Gene 1 (BRCA1) Product and Its Associated Proteins. Biological Chemistry 1999;380. [DOI: 10.1515/bc.1999.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
79 Li L, Liu L, Rao JN, Esmaili A, Strauch ED, Bass BL, Wang JY. JunD stabilization results in inhibition of normal intestinal epithelial cell growth through P21 after polyamine depletion. Gastroenterology 2002;123:764-79. [PMID: 12198703 DOI: 10.1053/gast.2002.35386] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 3.5] [Reference Citation Analysis]
80 Houvras Y, Benezra M, Zhang H, Manfredi JJ, Weber BL, Licht JD. BRCA1 Physically and Functionally Interacts with ATF1. Journal of Biological Chemistry 2000;275:36230-7. [DOI: 10.1074/jbc.m002539200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
81 Harkin DP. Uncovering Functionally Relevant Signaling Pathways Using Microarray‐Based Expression Profiling. The Oncologist 2000;5:501-7. [DOI: 10.1634/theoncologist.5-6-501] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
82 Li Y, Guo L, Ying S, Feng GH, Zhang Y. Transcriptional repression of p21 by EIF1AX promotes the proliferation of breast cancer cells. Cell Prolif 2020;53:e12903. [PMID: 32926483 DOI: 10.1111/cpr.12903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Daniel DC. Highlight: BRCA1 and BRCA2 proteins in breast cancer. Microsc Res Tech 2002;59:68-83. [PMID: 12242698 DOI: 10.1002/jemt.10178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
84 Park MA, Seok YJ, Jeong G, Lee JS. SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy. Nucleic Acids Res 2008;36:263-83. [PMID: 18025037 DOI: 10.1093/nar/gkm969] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
85 Wu C, Jeng J, Wang Y, Tseng C, Liang Y, Chen C, Lee H, Lin J, Lin C, Lin S, Li C, Ho Y. Antitumor Effects of Miconazole on Human Colon Carcinoma Xenografts in Nude Mice through Induction of Apoptosis and G0/G1 Cell Cycle Arrest. Toxicology and Applied Pharmacology 2002;180:22-35. [DOI: 10.1006/taap.2002.9352] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
86 Salisbury JL. The contribution of epigenetic changes to abnormal centrosomes and genomic instability in breast cancer. J Mammary Gland Biol Neoplasia 2001;6:203-12. [PMID: 11501580 DOI: 10.1023/a:1011312808421] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
87 Jones LP, Sampson A, Kang HJ, Kim HJ, Yi YW, Kwon SY, Babus JK, Wang A, Bae I. Loss of BRCA1 leads to an increased sensitivity to Bisphenol A. Toxicol Lett 2010;199:261-8. [PMID: 20868731 DOI: 10.1016/j.toxlet.2010.09.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
88 Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 2000;102:257-65. [PMID: 10943845 DOI: 10.1016/s0092-8674(00)00030-1] [Cited by in Crossref: 350] [Cited by in F6Publishing: 153] [Article Influence: 15.9] [Reference Citation Analysis]
89 Leung E, Hazrati LN. Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair. Brain Commun 2021;3:fcab117. [PMID: 34222870 DOI: 10.1093/braincomms/fcab117] [Reference Citation Analysis]
90 Fussenegger M, Bailey JE. Control of Mammalian Cell Proliferation as an Important Strategy in Cell Culture Technology, Cancer Therapy and Tissue Engineering. In: Al-rubeai M, editor. Cell Engineering. Dordrecht: Springer Netherlands; 1999. pp. 186-219. [DOI: 10.1007/978-0-585-37971-5_7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
91 Yan J, Zhu J, Zhong H, Lu Q, Huang C, Ye Q. BRCA1 interacts with FHL2 and enhances FHL2 transactivation function. FEBS Lett 2003;553:183-9. [PMID: 14550570 DOI: 10.1016/s0014-5793(03)00978-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
92 Scott RJ. DNA double strand break repair and its association with inherited predispositions to breast cancer. Hered Cancer Clin Pract 2004;2:37-43. [PMID: 20233482 DOI: 10.1186/1897-4287-2-1-37] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
93 Thompson LH, Schild D. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2001;477:131-53. [DOI: 10.1016/s0027-5107(01)00115-4] [Cited by in Crossref: 279] [Cited by in F6Publishing: 118] [Article Influence: 13.3] [Reference Citation Analysis]
94 Zhang Y, Dickman MB, Jones C. The Mycotoxin Fumonisin B1 Transcriptionally Activates the p21 Promoter through acis-Acting Element Containing Two Sp1 Binding Sites. Journal of Biological Chemistry 1999;274:12367-71. [DOI: 10.1074/jbc.274.18.12367] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
95 Wu SY, Chiang CM. Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding. EMBO J 2009;28:1246-59. [PMID: 19339993 DOI: 10.1038/emboj.2009.83] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 6.2] [Reference Citation Analysis]
96 Somasundaram V, Srinivas P. Insights into the targeted elimination of BRCA1-defective cancer stem cells: TARGETING BRCA1-DEFECTIVE CANCER STEM CELLS. Med Res Rev 2012;32:948-67. [DOI: 10.1002/med.20229] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
97 Zhou X, Yang Y, Ma P, Wang N, Yang D, Tu Q, Sun B, Xiang T, Zhao X, Hou Z, Fang X. TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway. J Neurooncol 2019;145:211-22. [DOI: 10.1007/s11060-019-03301-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
98 Yi YW, Kang HJ, Bae I. BRCA1 and Oxidative Stress. Cancers (Basel) 2014;6:771-95. [PMID: 24704793 DOI: 10.3390/cancers6020771] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
99 Shao JC, Wu JF, Wang DB, Qin R, Zhang H. Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance. World J Gastroenterol 2003; 9(3): 427-431 [PMID: 12632490 DOI: 10.3748/wjg.v9.i3.427] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
100 Scully R, Ganesan S, Vlasakova K, Chen J, Socolovsky M, Livingston DM. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol Cell 1999;4:1093-9. [PMID: 10635334 DOI: 10.1016/s1097-2765(00)80238-5] [Cited by in Crossref: 245] [Cited by in F6Publishing: 126] [Article Influence: 11.1] [Reference Citation Analysis]
101 Huttley GA, Easteal S, Southey MC, Tesoriero A, Giles GG, Mccredie MR, Hopper JL, Venter DJ. Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Nat Genet 2000;25:410-3. [DOI: 10.1038/78092] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 3.2] [Reference Citation Analysis]
102 Cairns J, Ingle JN, Wickerham LD, Weinshilboum R, Liu M, Wang L. SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1. PLoS Genet 2017;13:e1007031. [PMID: 28968398 DOI: 10.1371/journal.pgen.1007031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
103 Suen TC, Goss PE. Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 Bi-directional promoter. J Biol Chem 1999;274:31297-304. [PMID: 10531328 DOI: 10.1074/jbc.274.44.31297] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.1] [Reference Citation Analysis]
104 Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ, El-Deiry WS. BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol. 2002;4:842-849. [PMID: 12402042 DOI: 10.1038/ncb866] [Cited by in Crossref: 282] [Cited by in F6Publishing: 268] [Article Influence: 15.7] [Reference Citation Analysis]
105 Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2011;12:68-78. [PMID: 22193408 DOI: 10.1038/nrc3181] [Cited by in Crossref: 703] [Cited by in F6Publishing: 662] [Article Influence: 63.9] [Reference Citation Analysis]
106 Schneider L, Branchini G, Cericatto R, Capp E, Brum IS. Gene and protein expression of p53 and p21 in fibroadenomas and adjacent normal mammary tissue. Endocr 2009;35:118-22. [DOI: 10.1007/s12020-008-9124-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
107 Yuan R, Fan S, Wang J, Meng Q, Ma Y, Schreiber D, Goldberg ID, Rosen EM. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells. Prostate 1999;40:37-49. [DOI: 10.1002/(sici)1097-0045(19990615)40:1<37::aid-pros5>3.0.co;2-p] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
108 Paull TT, Cortez D, Bowers B, Elledge SJ, Gellert M. Direct DNA binding by Brca1. Proc Natl Acad Sci U S A. 2001;98:6086-6091. [PMID: 11353843 DOI: 10.1073/pnas.111125998] [Cited by in Crossref: 164] [Cited by in F6Publishing: 159] [Article Influence: 7.8] [Reference Citation Analysis]
109 Bove B, Dunbrack R, Godwin A. BRCA-1, BRCA-2 and Hereditary Breast Cancer. In: Pasqualini J, editor. Breast Cancer. CRC Press; 2002. pp. 555-624. [DOI: 10.1201/b14039-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
110 Sheikh MS, Hollander MC, Fornance AJ. Role of Gadd45 in apoptosis. Biochem Pharmacol. 2000;59:43-45. [PMID: 10605933 DOI: 10.1016/S0006-2952(99)00291-9] [Cited by in Crossref: 133] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
111 Tan W, Zheng L, Lee WH, Boyer TG. Functional dissection of transcription factor ZBRK1 reveals zinc fingers with dual roles in DNA-binding and BRCA1-dependent transcriptional repression. J Biol Chem 2004;279:6576-87. [PMID: 14660588 DOI: 10.1074/jbc.M312270200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
112 Nagata D, Suzuki E, Nishimatsu H, Yoshizumi M, Mano T, Walsh K, Sata M, Kakoki M, Goto A, Omata M, Hirata Y. Cyclin A downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells. Circ Res 2000;87:699-704. [PMID: 11029406 DOI: 10.1161/01.res.87.8.699] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
113 Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 2004;95:866-871. [PMID: 15546503 DOI: 10.1111/j.1349-7006.2004.tb02195.x] [Cited by in Crossref: 318] [Cited by in F6Publishing: 293] [Article Influence: 18.7] [Reference Citation Analysis]
114 Moloudizargari M, Moradkhani F, Hekmatirad S, Fallah M, Asghari MH, Reiter RJ. Therapeutic targets of cancer drugs: Modulation by melatonin. Life Sci 2021;267:118934. [PMID: 33385405 DOI: 10.1016/j.lfs.2020.118934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
115 Deng LW, Chiu I, Strominger JL. MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. Proc Natl Acad Sci U S A 2004;101:757-62. [PMID: 14718661 DOI: 10.1073/pnas.2036345100] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
116 Fan S, Yuan R, Ma YX, Meng Q, Goldberg ID, Rosen EM. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene 2001;20:8215-35. [DOI: 10.1038/sj.onc.1205033] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 2.2] [Reference Citation Analysis]
117 Robinson-Benion C, Jensen RA, Holt JT. Analysis of cancer gene functions through gene inhibition with antisense oligonucleotides. Methods Enzymol 2000;314:499-506. [PMID: 10565035 DOI: 10.1016/s0076-6879(99)14125-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
118 Zhang H, Davies KJA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med 2015;88:314-36. [PMID: 26066302 DOI: 10.1016/j.freeradbiomed.2015.05.036] [Cited by in Crossref: 356] [Cited by in F6Publishing: 334] [Article Influence: 50.9] [Reference Citation Analysis]
119 Deng CX. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice. Mutat Res 2001;477:183-9. [PMID: 11376699 DOI: 10.1016/s0027-5107(01)00119-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
120 Agoulnik IU, Tong X, Fischer D, Körner K, Atkinson NE, Edwards DP, Headon DR, Weigel NL, Kieback DG. A Germline Variation in the Progesterone Receptor Gene Increases Transcriptional Activity and May Modify Ovarian Cancer Risk. The Journal of Clinical Endocrinology & Metabolism 2004;89:6340-7. [DOI: 10.1210/jc.2004-0114] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
121 Ohta T, Fukuda M. Ubiquitin and breast cancer. Oncogene. 2004;23:2079-2088. [PMID: 15021895 DOI: 10.1038/sj.onc.1207371] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 4.4] [Reference Citation Analysis]
122 Niwa Y, Oyama T, Nakajima T. BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers. Jpn J Cancer Res 2000;91:519-26. [PMID: 10835497 DOI: 10.1111/j.1349-7006.2000.tb00976.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
123 Perlman H, Suzuki E, Simonson M, Smith RC, Walsh K. GATA-6 Induces p21Cip1 Expression and G1Cell Cycle Arrest. Journal of Biological Chemistry 1998;273:13713-8. [DOI: 10.1074/jbc.273.22.13713] [Cited by in Crossref: 92] [Cited by in F6Publishing: 88] [Article Influence: 3.8] [Reference Citation Analysis]
124 Pulukuri SM, Knost JA, Estes N, Rao JS. Small interfering RNA-directed knockdown of uracil DNA glycosylase induces apoptosis and sensitizes human prostate cancer cells to genotoxic stress. Mol Cancer Res 2009;7:1285-93. [PMID: 19671688 DOI: 10.1158/1541-7786.MCR-08-0508] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
125 Aghmesheh M, Nesland JM, Kaern J, Dorum A, Edwards L, Byth K, Friedlander M, Jackson P, Tucker KM, Russell PJ. No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers. Gynecologic Oncology 2004;95:430-6. [DOI: 10.1016/j.ygyno.2004.08.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
126 Xiong J, Fan S, Meng Q, Schramm L, Wang C, Bouzahza B, Zhou J, Zafonte B, Goldberg ID, Haddad BR, Pestell RG, Rosen EM. BRCA1 inhibition of telomerase activity in cultured cells. Mol Cell Biol 2003;23:8668-90. [PMID: 14612409 DOI: 10.1128/MCB.23.23.8668-8690.2003] [Cited by in Crossref: 61] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
127 Ng T, Irshad S, Stebbing J. BRCA1 mutations and luminal-basal transformation. Oncogene 2013;32:2712-4. [PMID: 22926516 DOI: 10.1038/onc.2012.379] [Reference Citation Analysis]
128 de la Hoya M, Díaz-rubio E, Caldés T. Denaturing Gradient Gel Electrophoresis-based Analysis of Loss of Heterozygosity Distinguishes Nonobvious, Deleterious BRCA1 Variants from Nonpathogenic Polymorphisms. Clinical Chemistry 1999;45:2028-30. [DOI: 10.1093/clinchem/45.11.2028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
129 Kumar A, Knott C, Kuus-Reichel K, Saedi MS. BRCA1 partially reverses the transforming activity of the ras oncogene. Neoplasia 1999;1:417-23. [PMID: 10933056 DOI: 10.1038/sj.neo.7900058] [Reference Citation Analysis]
130 Randrianarison V, Marot D, Foray N, Cabannes J, Méret V, Connault E, Vitrat N, Opolon P, Perricaudet M, Feunteun J. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21. Cancer Gene Ther 2001;8:759-70. [PMID: 11687899 DOI: 10.1038/sj.cgt.7700366] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
131 Archer SY, Johnson JJ, Kim HJ, Hodin RA. p21 gene regulation during enterocyte differentiation. J Surg Res. 2001;98:4-8. [PMID: 11368530 DOI: 10.1006/jsre.2001.6147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
132 Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, Suzuki T, Tsuruo T, Nakanishi O. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci U S A. 1999;96:4592-4597. [PMID: 10200307 DOI: 10.1073/pnas.96.8.4592] [Cited by in Crossref: 501] [Cited by in F6Publishing: 467] [Article Influence: 21.8] [Reference Citation Analysis]
133 Tworek H, Peng R, Fetzer S, Werness BA, Piver MS, Allen HJ, DiCioccio RA. Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors. Cancer Genet Cytogenet 1999;112:105-18. [PMID: 10686936 DOI: 10.1016/s0165-4608(98)00267-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
134 Zheng L, Annab LA, Afshari CA, Lee WH, Boyer TG. BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc Natl Acad Sci U S A 2001;98:9587-92. [PMID: 11493692 DOI: 10.1073/pnas.171174298] [Cited by in Crossref: 129] [Cited by in F6Publishing: 132] [Article Influence: 6.1] [Reference Citation Analysis]
135 Jang ER, Lee JS. DNA damage response mediated through BRCA1. Cancer Res Treat 2004;36:214-21. [PMID: 20368837 DOI: 10.4143/crt.2004.36.4.214] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
136 Zhang SL, Li BL, Li W, Lu M, Ni LY, Ma HL, Meng QG. The Effects of Ludartin on Cell Proliferation, Cell Migration, Cell Cycle Arrest and Apoptosis Are Associated with Upregulation of p21WAF1 in Saos-2 Osteosarcoma Cells In Vitro. Med Sci Monit 2018;24:4926-33. [PMID: 30008466 DOI: 10.12659/MSM.909193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
137 Chang S, Biswas K, Martin BK, Stauffer S, Sharan SK. Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations. J Clin Invest 2009;119:3160-71. [PMID: 19770520 DOI: 10.1172/JCI39836] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
138 Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM. CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci U S A 2000;97:1020-5. [PMID: 10655477 DOI: 10.1073/pnas.97.3.1020] [Cited by in Crossref: 136] [Cited by in F6Publishing: 135] [Article Influence: 6.2] [Reference Citation Analysis]
139 Ostrow KL, McGuire V, Whittemore AS, DiCioccio RA. The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity. Cancer Genet Cytogenet 2004;153:177-80. [PMID: 15350310 DOI: 10.1016/j.cancergencyto.2004.01.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
140 Donadelli M, Dalla Pozza E, Costanzo C, Scupoli MT, Piacentini P, Scarpa A, Palmieri M. Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate. Biochim Biophys Acta 2006;1763:917-26. [PMID: 16904205 DOI: 10.1016/j.bbamcr.2006.05.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
141 Chalabi N, Delort L, Le Corre L, Satih S, Bignon YJ, Bernard-Gallon D. Gene signature of breast cancer cell lines treated with lycopene. Pharmacogenomics 2006;7:663-72. [PMID: 16886892 DOI: 10.2217/14622416.7.5.663] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
142 Milutinovic S, Knox JD, Szyf M. DNA methyltransferase inhibition induces the transcription of the tumor suppressor p21(WAF1/CIP1/sdi1). J Biol Chem. 2000;275:6353-6359. [PMID: 10692435 DOI: 10.1074/jbc.275.9.6353] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 3.9] [Reference Citation Analysis]
143 Mullan PB, Quinn JE, Harkin DP. The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene. 2006;25:5854-5863. [PMID: 16998500 DOI: 10.1038/sj.onc.1209872] [Cited by in Crossref: 191] [Cited by in F6Publishing: 179] [Article Influence: 11.9] [Reference Citation Analysis]
144 O'Brien KA, Lemke SJ, Cocke KS, Rao RN, Beckmann RP. Casein kinase 2 binds to and phosphorylates BRCA1. Biochem Biophys Res Commun 1999;260:658-64. [PMID: 10403822 DOI: 10.1006/bbrc.1999.0892] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
145 Schlegel BP, Starita LM, Parvin JD. Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells. Oncogene 2003;22:983-91. [DOI: 10.1038/sj.onc.1206195] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 3.6] [Reference Citation Analysis]
146 Hinton CV, Fitzgerald LD, Thompson ME. Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1. Exp Cell Res 2007;313:1735-44. [PMID: 17428466 DOI: 10.1016/j.yexcr.2007.03.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
147 Schuyer M, Berns EM. Is TP53 dysfunction required for BRCA1-associated carcinogenesis? Mol Cell Endocrinol 1999;155:143-52. [PMID: 10580847 DOI: 10.1016/s0303-7207(99)00117-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
148 Xin–hua B, Rui–yu L. Progress in research on correlation among STAT3, CyclinD1, P21 genes and tumors. Journal of Otology 2012;7:19-24. [DOI: 10.1016/s1672-2930(12)50005-x] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
149 Ye Q, Hu YF, Zhong H, Nye AC, Belmont AS, Li R. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol 2001;155:911-21. [PMID: 11739404 DOI: 10.1083/jcb.200108049] [Cited by in Crossref: 131] [Cited by in F6Publishing: 140] [Article Influence: 6.2] [Reference Citation Analysis]
150 Duncan JA, Reeves JR, Cooke TG. BRCA1 and BRCA2 proteins: roles in health and disease. Mol Pathol 1998;51:237-47. [PMID: 10193517 DOI: 10.1136/mp.51.5.237] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
151 De Potter CR, Coene ED, Schelfhout VR. Localization of BRCA1 protein at the cellular level. J Mammary Gland Biol Neoplasia 1998;3:423-9. [PMID: 10819536 DOI: 10.1023/a:1018740216630] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
152 Kivinen L, Tsubari M, Haapajärvi T, Datto MB, Wang X, Laiho M. Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites. Oncogene 1999;18:6252-61. [DOI: 10.1038/sj.onc.1203000] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 2.0] [Reference Citation Analysis]
153 Glover-Collins K, Thompson ME. Nuclear export of BRCA1 occurs during early S phase and is calcium-dependent. Cell Signal 2008;20:958-68. [PMID: 18296025 DOI: 10.1016/j.cellsig.2008.01.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
154 Lyngsø C, Bouteiller G, Damgaard CK, Ryom D, Sanchez-muñoz S, Nørby PL, Bonven BJ, Jørgensen P. Interaction between the Transcription Factor SPBP and the Positive Cofactor RNF4. Journal of Biological Chemistry 2000;275:26144-9. [DOI: 10.1074/jbc.m003405200] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
155 Mahyar-roemer M, Roemer K. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 2001;20:3387-98. [DOI: 10.1038/sj.onc.1204440] [Cited by in Crossref: 117] [Cited by in F6Publishing: 110] [Article Influence: 5.6] [Reference Citation Analysis]
156 Cha HH, Cram EJ, Wang EC, Huang AJ, Kasler HG, Firestone GL. Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells. J Biol Chem 1998;273:1998-2007. [PMID: 9442036 DOI: 10.1074/jbc.273.4.1998] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 3.5] [Reference Citation Analysis]
157 Wan Q, Liu Z, Peng W, Wang J, Li X, Yang Y. BnRCH gene inhibits cell growth of Hela cells through increasing the G2 phase of cell cycle. Hum Cell 2011;24:150-60. [PMID: 22038067 DOI: 10.1007/s13577-011-0036-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
158 Brodie KM, Henderson BR. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage. Cell Signal 2010;22:291-302. [PMID: 19796682 DOI: 10.1016/j.cellsig.2009.09.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
159 Kim MJ, Yoo YA, Kim HJ, Kang S, Kim YG, Kim JS, Yoo YD. Mitochondrial ribosomal protein L41 mediates serum starvation-induced cell-cycle arrest through an increase of p21(WAF1/CIP1). Biochem Biophys Res Commun. 2005;338:1179-1184. [PMID: 16256947 DOI: 10.1016/j.bbrc.2005.10.064] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
160 Chehade R, Pettapiece-Phillips R, Salmena L, Kotlyar M, Jurisica I, Narod SA, Akbari MR, Kotsopoulos J. Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific. Breast Cancer Res 2016;18:87. [PMID: 27534398 DOI: 10.1186/s13058-016-0739-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
161 Fabbro M, Schuechner S, Au WW, Henderson BR. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention. Exp Cell Res 2004;298:661-73. [PMID: 15265711 DOI: 10.1016/j.yexcr.2004.05.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 2.9] [Reference Citation Analysis]
162 Zhang N, Lu Y, Liu X, Yu D, Lv Z, Yang M. Functional Evaluation of ZNF350 Missense Genetic Variants Associated with Breast Cancer Susceptibility. DNA Cell Biol 2018;37:543-50. [PMID: 29653063 DOI: 10.1089/dna.2018.4160] [Reference Citation Analysis]
163 Li S, Ting NS, Zheng L, Chen PL, Ziv Y, Shiloh Y, Lee EY, Lee WH. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 2000;406:210-5. [PMID: 10910365 DOI: 10.1038/35018134] [Cited by in Crossref: 216] [Cited by in F6Publishing: 203] [Article Influence: 9.8] [Reference Citation Analysis]
164 Yadav LR, Biswal MN, Hosur M, Kumar NS, Varma AK. Structural basis to characterise transactivation domain of BRCA1. Journal of Biomolecular Structure and Dynamics 2017;35:1-7. [DOI: 10.1080/07391102.2015.1136896] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
165 Haapajärvi T, Kivinen L, Heiskanen A, des Bordes C, Datto MB, Wang X, Laiho M. UV Radiation Is a Transcriptional Inducer of p21Cip1/Waf1Cyclin-Kinase Inhibitor in a p53-Independent Manner. Experimental Cell Research 1999;248:272-9. [DOI: 10.1006/excr.1999.4403] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 1.8] [Reference Citation Analysis]
166 Rodriguez JA, Au WW, Henderson BR. Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain. Exp Cell Res 2004;293:14-21. [PMID: 14729053 DOI: 10.1016/j.yexcr.2003.09.027] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
167 Wang X, Wang R, Li W, Xu X, Hollander MC, Fornace AJ, Deng C. Genetic Interactions between Brca1 and Gadd45a in Centrosome Duplication, Genetic Stability, and Neural Tube Closure. Journal of Biological Chemistry 2004;279:29606-14. [DOI: 10.1074/jbc.m312279200] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
168 Lafarge S, Sylvain V, Ferrara M, Bignon Y. Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway. Oncogene 2001;20:6597-606. [DOI: 10.1038/sj.onc.1204812] [Cited by in Crossref: 129] [Cited by in F6Publishing: 120] [Article Influence: 6.1] [Reference Citation Analysis]
169 Fan W, Jin S, Tong T, Zhao H, Fan F, Antinore MJ, Rajasekaran B, Wu M, Zhan Q. BRCA1 Regulates GADD45 through Its Interactions with the OCT-1 and CAAT Motifs. Journal of Biological Chemistry 2002;277:8061-7. [DOI: 10.1074/jbc.m110225200] [Cited by in Crossref: 97] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
170 Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. The Role of BRCA1 in the Cellular Response to Chemotherapy. JNCI Journal of the National Cancer Institute 2004;96:1659-68. [DOI: 10.1093/jnci/djh312] [Reference Citation Analysis]
171 de La Fuente C, Santiago F, Chong SY, Deng L, Mayhood T, Fu P, Stein D, Denny T, Coffman F, Azimi N, Mahieux R, Kashanchi F. Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2. J Virol 2000;74:7270-83. [PMID: 10906181 DOI: 10.1128/jvi.74.16.7270-7283.2000] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
172 Au WW, Henderson BR. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage. Cell Signal 2007;19:1879-92. [PMID: 17531442 DOI: 10.1016/j.cellsig.2007.04.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
173 Mullan PB, Quinn JE, Gilmore PM, Mcwilliams S, Andrews H, Gervin C, Mccabe N, Mckenna S, White P, Song Y, Maheswaran S, Liu E, Haber DA, Johnston PG, Harkin DP. BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents. Oncogene 2001;20:6123-31. [DOI: 10.1038/sj.onc.1204712] [Cited by in Crossref: 110] [Cited by in F6Publishing: 104] [Article Influence: 5.2] [Reference Citation Analysis]
174 Spierings DC, de Vries EG, Stel AJ, te Rietstap N, Vellenga E, de Jong S. Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis. Oncogene 2004;23:4862-72. [PMID: 15122333 DOI: 10.1038/sj.onc.1207617] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
175 Yair D, Ben Baruch G, Chetrit A, Friedman T, Yechezkel GH, Gotlieb WH, Fishman A, Belter U, Bar-am A, Friedman E. p53 and WAF1 polymorphisms in Jewish-Israeli women with epithelial ovarian cancer and its association with BRCA mutations. BJOG:An international journal of O&G 2000;107:849-54. [DOI: 10.1111/j.1471-0528.2000.tb11082.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
176 Nadeau G, Boufaied N, Moisan A, Lemieux KM, Cayanan C, Monteiro AN, Gaudreau L. BRCA1 can stimulate gene transcription by a unique mechanism. EMBO Rep 2000;1:260-5. [PMID: 11256609 DOI: 10.1093/embo-reports/kvd059] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
177 Zhou C, Huang P, Liu J. The carboxyl-terminal of BRCA1 is required for subnuclear assembly of RAD51 after treatment with cisplatin but not ionizing radiation in human breast and ovarian cancer cells. Biochemical and Biophysical Research Communications 2005;336:952-60. [DOI: 10.1016/j.bbrc.2005.08.197] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
178 Gaiser OJ, Ball LJ, Schmieder P, Leitner D, Strauss H, Wahl M, Kühne R, Oschkinat H, Heinemann U. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1. Biochemistry 2004;43:15983-95. [PMID: 15609993 DOI: 10.1021/bi049550q] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
179 Fabbro M, Henderson BR. BARD1 regulates BRCA1-mediated transactivation of the p21WAF1/CIP1 and Gadd45 promoters. Cancer Lett 2008;263:189-96. [PMID: 18243530 DOI: 10.1016/j.canlet.2008.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
180 Turesson I, Nyman J, Qvarnström F, Simonsson M, Book M, Hermansson I, Sigurdardottir S, Johansson K. A low-dose hypersensitive keratinocyte loss in response to fractionated radiotherapy is associated with growth arrest and apoptosis. Radiotherapy and Oncology 2010;94:90-101. [DOI: 10.1016/j.radonc.2009.10.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
181 Das S, Nama S, Antony S, Somasundaram K. p73 beta-expressing recombinant adenovirus: a potential anticancer agent. Cancer Gene Ther 2005;12:417-26. [PMID: 15678153 DOI: 10.1038/sj.cgt.7700803] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
182 Armes JE, Egan AJM, Southey MC, Dite GS, Mccredie MRE, Giles GG, Hopper JL, Venter DJ. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: A population-based study. Cancer 1998;83:2335-45. [DOI: 10.1002/(sici)1097-0142(19981201)83:11<2335::aid-cncr13>3.0.co;2-n] [Cited by in Crossref: 170] [Cited by in F6Publishing: 1] [Article Influence: 7.1] [Reference Citation Analysis]
183 Langerud J, Jarhelle E, Van Ghelue M, Ariansen SL, Iversen N. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance. Hum Genomics 2018;12:51. [PMID: 30458859 DOI: 10.1186/s40246-018-0183-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
184 Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene. 2003;22:5834-5847. [PMID: 12947390 DOI: 10.1038/sj.onc.1206682] [Cited by in Crossref: 305] [Cited by in F6Publishing: 262] [Article Influence: 16.1] [Reference Citation Analysis]
185 Benezra M, Chevallier N, Morrison DJ, MacLachlan TK, El-Deiry WS, Licht JD. BRCA1 augments transcription by the NF-kappaB transcription factor by binding to the Rel domain of the p65/RelA subunit. J Biol Chem 2003;278:26333-41. [PMID: 12700228 DOI: 10.1074/jbc.M303076200] [Cited by in Crossref: 56] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
186 Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. The role of BRCA1 in the cellular response to chemotherapy. J Natl Cancer Inst. 2004;96:1659-1668. [PMID: 15547178 DOI: 10.1093/jnci/djh312] [Cited by in Crossref: 297] [Cited by in F6Publishing: 263] [Article Influence: 16.5] [Reference Citation Analysis]
187 Linger RJ, Kruk PA. BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications. FEBS J 2010;277:3086-96. [PMID: 20608970 DOI: 10.1111/j.1742-4658.2010.07735.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
188 Tong D, Stimpfl M, Reinthaller A, Vavra N, Müllauer-ertl S, Leodolter S, Zeillinger R. BRCA1 Gene Mutations in Sporadic Ovarian Carcinomas: Detection by PCR and Reverse Allele-specific Oligonucleotide Hybridization. Clinical Chemistry 1999;45:976-81. [DOI: 10.1093/clinchem/45.7.976] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
189 Yarden RI, Brody LC. BRCA1 interacts with components of the histone deacetylase complex. Proc Natl Acad Sci U S A 1999;96:4983-8. [PMID: 10220405 DOI: 10.1073/pnas.96.9.4983] [Cited by in Crossref: 214] [Cited by in F6Publishing: 220] [Article Influence: 9.3] [Reference Citation Analysis]
190 Ouchi T, Lee SW, Ouchi M, Aaronson SA, Horvath CM. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. Proc Natl Acad Sci U S A 2000;97:5208-13. [PMID: 10792030 DOI: 10.1073/pnas.080469697] [Cited by in Crossref: 147] [Cited by in F6Publishing: 149] [Article Influence: 6.7] [Reference Citation Analysis]
191 Gizard F, Robillard R, Gross B, Barbier O, Révillion F, Peyrat JP, Torpier G, Hum DW, Staels B. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone. Mol Cell Biol 2006;26:7632-44. [PMID: 17015480 DOI: 10.1128/MCB.00326-06] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
192 Jeffy BD, Hockings JK, Kemp MQ, Morgan SS, Hager JA, Beliakoff J, Whitesell LJ, Bowden GT, Romagnolo DF. An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription. Neoplasia 2005;7:873-82. [PMID: 16229810 DOI: 10.1593/neo.05256] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
193 Annab LA, Kouprina N, Solomon G, Cable PL, Hill DE, Barrett JC, Larionov V, Afshari CA. Isolation of a functional copy of the human BRCA1 gene by transformation-associated recombination in yeast. Gene 2000;250:201-8. [PMID: 10854793 DOI: 10.1016/s0378-1119(00)00180-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
194 Sax JK, El-Deiry WS. Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene. J Biol Chem 2003;278:36435-44. [PMID: 12788948 DOI: 10.1074/jbc.M303191200] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
195 Kote-Jarai Z, Eeles RA. BRCA1, BRCA2 and their possible function in DNA damage response. Br J Cancer 1999;81:1099-102. [PMID: 10584867 DOI: 10.1038/sj.bjc.6690814] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
196 Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 in hormone-responsive cancers. Trends in Endocrinology & Metabolism 2003;14:378-85. [DOI: 10.1016/j.tem.2003.08.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
197 Wu W, Koike A, Takeshita T, Ohta T. The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Div 2008;3:1. [PMID: 18179693 DOI: 10.1186/1747-1028-3-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
198 Chappuis PO, Kapusta L, Bégin LR, Wong N, Brunet J, Narod SA, Slingerland J, Foulkes WD. Germline BRCA1/2 Mutations and p27 Kip1 Protein Levels Independently Predict Outcome After Breast Cancer. JCO 2000;18:4045-52. [DOI: 10.1200/jco.2000.18.24.4045] [Cited by in Crossref: 90] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
199 Hu J, Ma X, Lindner DJ, Karra S, Hofmann ER, Reddy SP, Kalvakolanu DV. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination. Oncogene 2001;20:4235-48. [PMID: 11464290 DOI: 10.1038/sj.onc.1204585] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
200 Ouchi T, Monteiro AN, August A, Aaronson SA, Hanafusa H. BRCA1 regulates p53-dependent gene expression. Proc Natl Acad Sci U S A 1998;95:2302-6. [PMID: 9482880 DOI: 10.1073/pnas.95.5.2302] [Cited by in Crossref: 234] [Cited by in F6Publishing: 254] [Article Influence: 9.8] [Reference Citation Analysis]
201 Guo R, Ma Y, Zhao M, Zhang W, An G, Chen B, Song Y, Xu H, Li Y. Polymorphism rs2395655 affects LEDGF/p75 binding activity and p21WAF1/CIP1 gene expression in esophageal squamous cell carcinoma. Cancer Med 2019;8:2313-24. [PMID: 30854807 DOI: 10.1002/cam4.2067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
202 Yu X, Wu LC, Bowcock AM, Aronheim A, Baer R. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J Biol Chem 1998;273:25388-92. [PMID: 9738006 DOI: 10.1074/jbc.273.39.25388] [Cited by in Crossref: 257] [Cited by in F6Publishing: 279] [Article Influence: 10.7] [Reference Citation Analysis]
203 Göhring UJ, Bersch A, Becker M, Neuhaus W, Schöndorf T. p21(waf) correlates with DNA replication but not with prognosis in invasive breast cancer. J Clin Pathol 2001;54:866-70. [PMID: 11684722 DOI: 10.1136/jcp.54.11.866] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
204 Mann GB, Borgen PI. Breast cancer genes and the surgeon. J Surg Oncol 1998;67:267-74. [DOI: 10.1002/(sici)1096-9098(199804)67:4<267::aid-jso12>3.0.co;2-y] [Cited by in Crossref: 19] [Article Influence: 0.8] [Reference Citation Analysis]
205 Hu YF, Hao ZL, Li R. Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1. Genes Dev 1999;13:637-42. [PMID: 10090719 DOI: 10.1101/gad.13.6.637] [Cited by in Crossref: 78] [Cited by in F6Publishing: 85] [Article Influence: 3.4] [Reference Citation Analysis]
206 Chai Y, Chipitsyna G, Cui J, Liao B, Liu S, Aysola K, Yezdani M, Reddy ES, Rao VN. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. Oncogene. 2001;20:1357-1367. [PMID: 11313879 DOI: 10.1038/sj.onc.1204256] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 1.9] [Reference Citation Analysis]
207 Liu B, Cong R, Peng B, Zhu B, Dou G, Ai H, Zhang X, Wang Z, Xu X. CtIP is required for DNA damage-dependent induction of P21. Cell Cycle 2014;13:90-5. [PMID: 24196441 DOI: 10.4161/cc.26810] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
208 Dimitrov SD, Lu D, Naetar N, Hu Y, Pathania S, Kanellopoulou C, Livingston DM. Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle. Genes Dev 2013;27:2274-91. [PMID: 24142877 DOI: 10.1101/gad.225045.113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
209 Ongusaha PP, Ouchi T, Kim KT, Nytko E, Kwak JC, Duda RB, Deng CX, Lee SW. BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest. Oncogene 2003;22:3749-58. [PMID: 12802282 DOI: 10.1038/sj.onc.1206439] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 1.8] [Reference Citation Analysis]
210 Ratanaphan A. A DNA repair BRCA1 estrogen receptor and targeted therapy in breast cancer. Int J Mol Sci 2012;13:14898-916. [PMID: 23203101 DOI: 10.3390/ijms131114898] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
211 Moisan A, Gaudreau L. The BRCA1 COOH-terminal region acts as an RNA polymerase II carboxyl-terminal domain kinase inhibitor that modulates p21WAF1/CIP1 expression. J Biol Chem 2006;281:21119-30. [PMID: 16735508 DOI: 10.1074/jbc.M600712200] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
212 Moustakas A, Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA. 1998;95:6733-6738. [PMID: 9618481 DOI: 10.1073/pnas.95.12.6733] [Cited by in Crossref: 262] [Cited by in F6Publishing: 264] [Article Influence: 10.9] [Reference Citation Analysis]
213 Somasundaram K. Breast cancer gene 1 (BRCA1): Role in cell cycle regulation and DNA repair?perhaps through transcription. J Cell Biochem 2003;88:1084-91. [DOI: 10.1002/jcb.10469] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
214 Zheng L, Pan H, Li S, Flesken-Nikitin A, Chen PL, Boyer TG, Lee WH. Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Mol Cell. 2000;6:757-768. [PMID: 11090615 DOI: 10.1016/s1097-2765(00)00075-7] [Cited by in Crossref: 163] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
215 Haber D. BRCA1: an emerging role in the cellular response to DNA damage. The Lancet 2000;355:2090-1. [DOI: 10.1016/s0140-6736(00)02371-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
216 Xie HL, Su Q, He XS, Liang XQ, Zhou JG, Song Y, Li YQ. Expression of p21WAF1 and p53 and polymorphism of p21WAF1 gene in gastric carcinoma. World J Gastroenterol 2004; 10(8): 1125-1131 [PMID: 15069711 DOI: 10.3748/wjg.v10.i8.1125] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
217 Bonduelle C, Lecommandoux S. Synthetic Glycopolypeptides as Biomimetic Analogues of Natural Glycoproteins. Biomacromolecules 2013;14:2973-83. [DOI: 10.1021/bm4008088] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 8.9] [Reference Citation Analysis]
218 Okada S, Ouchi T. Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affect its subcellular localization. J Biol Chem 2003;278:2015-20. [PMID: 12427729 DOI: 10.1074/jbc.M208685200] [Cited by in Crossref: 53] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
219 Baer R, Lee WH. Functional domains of the BRCA1 and BRCA2 proteins. J Mammary Gland Biol Neoplasia 1998;3:403-12. [PMID: 10819534 DOI: 10.1023/a:1018736115722] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
220 Donnellan R, Chetty R. Cyclin E in human cancers. FASEB j 1999;13:773-80. [DOI: 10.1096/fasebj.13.8.773] [Cited by in Crossref: 143] [Cited by in F6Publishing: 132] [Article Influence: 6.2] [Reference Citation Analysis]
221 Thomas MC, Chiang CM. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation. Mol Cell 2005;17:251-64. [PMID: 15664194 DOI: 10.1016/j.molcel.2004.12.016] [Cited by in Crossref: 143] [Cited by in F6Publishing: 139] [Article Influence: 8.4] [Reference Citation Analysis]
222 Hastak K, Agarwal MK, Mukhtar H, Agarwal ML. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J 2005;19:789-91. [PMID: 15764647 DOI: 10.1096/fj.04-2226fje] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 6.4] [Reference Citation Analysis]
223 Chen GC, Guan LS, Yu JH, Li GC, Choi Kim HR, Wang ZY. Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1. Biochem Biophys Res Commun 2001;284:507-14. [PMID: 11394910 DOI: 10.1006/bbrc.2001.5003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
224 Miralem T, Avraham HK. Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus. Mol Cell Biol 2003;23:579-93. [PMID: 12509456 DOI: 10.1128/MCB.23.2.579-593.2003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
225 Chen Y, Borowicz S, Fackenthal J, Collart FR, Myatt E, Moy S, Babnigg G, Wilton R, Boernke WE, Schiffer M, Stevens FJ, Olopade OI. Primary structure-based function characterization of BRCT domain replicates in BRCA1. Biochem Biophys Res Commun 2006;345:188-96. [PMID: 16677609 DOI: 10.1016/j.bbrc.2006.03.239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
226 Parvin JD, Young RA. Regulatory targets in the RNA polymerase II holoenzyme. Current Opinion in Genetics & Development 1998;8:565-70. [DOI: 10.1016/s0959-437x(98)80012-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
227 Liu JD, Wang YJ, Chen CH, Yu CF, Chen LC, Lin JK, Liang YC, Lin SY, Ho YS. Molecular mechanisms of G0/G1 cell-cycle arrest and apoptosis induced by terfenadine in human cancer cells. Mol Carcinog. 2003;37:39-50. [PMID: 12720299 DOI: 10.1002/mc.10118] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
228 Chiba N, Parvin JD. Redistribution of BRCA1 among four different protein complexes following replication blockage. J Biol Chem 2001;276:38549-54. [PMID: 11504724 DOI: 10.1074/jbc.M105227200] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
229 Gonzalez R, Silva JM, Dominguez G, Garcia JM, Martinez G, Vargas J, Provencio M, España P, Bonilla F. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Br J Cancer 1999;81:503-9. [PMID: 10507777 DOI: 10.1038/sj.bjc.6690722] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
230 Guendel I, Meltzer BW, Baer A, Dever SM, Valerie K, Guo J, Wu Y, Kehn-Hall K. BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection. Virol J 2015;12:40. [PMID: 25879655 DOI: 10.1186/s12985-015-0266-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
231 Monteiro AN. BRCA1: exploring the links to transcription. Trends in Biochemical Sciences 2000;25:469-74. [DOI: 10.1016/s0968-0004(00)01632-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
232 Zeng ZM, Du HY, Xiong L, Zeng XL, Zhang P, Cai J, Huang L, Liu AW. BRCA1 protects cardiac microvascular endothelial cells against irradiation by regulating p21-mediated cell cycle arrest. Life Sci 2020;244:117342. [PMID: 31978450 DOI: 10.1016/j.lfs.2020.117342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
233 Phelan CM, Dapic V, Tice B, Favis R, Kwan E, Barany F, Manoukian S, Radice P, van der Luijt RB, van Nesselrooij BP, Chenevix-Trench G, kConFab, Caldes T, de la Hoya M, Lindquist S, Tavtigian SV, Goldgar D, Borg A, Narod SA, Monteiro AN. Classification of BRCA1 missense variants of unknown clinical significance. J Med Genet 2005;42:138-46. [PMID: 15689452 DOI: 10.1136/jmg.2004.024711] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 4.2] [Reference Citation Analysis]
234 Maran A, Shogren KL, Benedikt M, Sarkar G, Turner RT, Yaszemski MJ. 2-methoxyestradiol-induced cell death in osteosarcoma cells is preceded by cell cycle arrest. J Cell Biochem 2008;104:1937-45. [PMID: 18384113 DOI: 10.1002/jcb.21758] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
235 Hu Y, Miyake T, Ye Q, Li R. Characterization of a Novel Trans-Activation Domain of BRCA1 That Functions in Concert with the BRCA1 C-terminal (BRCT) Domain. Journal of Biological Chemistry 2000;275:40910-5. [DOI: 10.1074/jbc.c000607200] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
236 Lee YH, Kuo CY, Stark JM, Shih HM, Ann DK. HP1 promotes tumor suppressor BRCA1 functions during the DNA damage response. Nucleic Acids Res 2013;41:5784-98. [PMID: 23589625 DOI: 10.1093/nar/gkt231] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
237 Yun J, Lee WH. Degradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damage. Mol Cell Biol. 2003;23:7305-7314. [PMID: 14517299 DOI: 10.1128/mcb.23.20.7305-7314.2003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
238 Altiok S, Batt D, Altiok N, Papautsky A, Downward J, Roberts TM, Avraham H. Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells. J Biol Chem. 1999;274:32274-32278. [PMID: 10542266 DOI: 10.1074/jbc.274.45.32274] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 3.5] [Reference Citation Analysis]
239 Jeffy BD, Chen EJ, Gudas JM, Romagnolo DF. Disruption of cell cycle kinetics by benzo[a]pyrene: inverse expression patterns of BRCA-1 and p53 in MCF-7 cells arrested in S and G2. Neoplasia 2000;2:460-70. [PMID: 11191113 DOI: 10.1038/sj.neo.7900104] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
240 Annab LA, Terry L, Cable P, Brady J, Stampfer MR, Barrett J, Afshari CA. Establishment and Characterization of a Breast Cell Strain Containing a BRCA1 185delAG Mutation. Gynecologic Oncology 2000;77:121-8. [DOI: 10.1006/gyno.2000.5734] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
241 Tarapore P, Horn HF, Tokuyama Y, Fukasawa K. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene 2001;20:3173-84. [PMID: 11423967 DOI: 10.1038/sj.onc.1204424] [Cited by in Crossref: 97] [Cited by in F6Publishing: 103] [Article Influence: 4.6] [Reference Citation Analysis]
242 Wang Q, Zhang H, Fishel R, Greene MI. BRCA1 and cell signaling. Oncogene. 2000;19:6152-6158. [PMID: 11156529 DOI: 10.1038/sj.onc.1203974] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 2.7] [Reference Citation Analysis]
243 Rosen EM, Fan S, Goldberg ID. BRCA1 and Prostate Cancer. Cancer Investigation 2001;19:396-412. [DOI: 10.1081/cnv-100103134] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
244 Annab LA, Hawkins RE, Solomon G, Barrett JC, Afshari CA. Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line. Breast Cancer Res 2000;2:139-48. [PMID: 11056686 DOI: 10.1186/bcr45] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
245 Mccullough SD, Hu Y, Li R. BRCA1 in initiation, invasion, and metastasis of breast cancer: a perspective from the tumor microenvironment. In: Mansel RE, Fodstad O, Jiang WG, editors. Metastasis of Breast Cancer. Dordrecht: Springer Netherlands; 2007. pp. 31-46. [DOI: 10.1007/978-1-4020-5867-7_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
246 Kiick KL. Biosynthetic Methods for the Production of Advanced Protein‐Based Materials. Polymer Reviews 2007;47:1-7. [DOI: 10.1080/15583720601109545] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
247 An JH, Jang SM, Kim JW, Kim CH, Song PI, Choi KH. The expression of p21 is upregulated by forkhead box A1/2 in p53-null H1299 cells. FEBS Lett. 2014;588:4065-4070. [PMID: 25281925 DOI: 10.1016/j.febslet.2014.09.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
248 Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, Abraham RT. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 2000;14:2989-3002. [PMID: 11114888 DOI: 10.1101/gad.851000] [Cited by in Crossref: 315] [Cited by in F6Publishing: 310] [Article Influence: 15.0] [Reference Citation Analysis]
249 Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell. 1999;3:389-395. [PMID: 10198641 DOI: 10.1016/s1097-2765(00)80466-9] [Cited by in Crossref: 534] [Cited by in F6Publishing: 196] [Article Influence: 23.2] [Reference Citation Analysis]
250 Young JI, Smith JR. DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. J Biol Chem. 2001;276:19610-19616. [PMID: 11259405 DOI: 10.1074/jbc.m009470200] [Cited by in Crossref: 52] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
251 Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. J Cell Physiol 2003;196:19-41. [PMID: 12767038 DOI: 10.1002/jcp.10257] [Cited by in Crossref: 141] [Cited by in F6Publishing: 141] [Article Influence: 7.4] [Reference Citation Analysis]
252 Chen KE, Bustamante K, Nguyen V, Walker AM. Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol. Oncotarget 2017;8:36368-82. [PMID: 28422740 DOI: 10.18632/oncotarget.16755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
253 Braun SE, Mantel C, Rosenthal M, Cooper S, Liu L, Robertson KA, Hromas R, Broxmeyer HE. A positive effect of p21cip1/waf1 in the colony formation from murine myeloid progenitor cells as assessed by retroviral-mediated gene transfer. Blood Cells Mol Dis. 1998;24:138-148. [PMID: 9628851 DOI: 10.1006/bcmd.1998.0181] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
254 Leaf S, Carlsen L, El-Deiry WS. Opposing effects of BRCA1 mRNA expression on patient survival in breast and colorectal cancer and variations among African American, Asian, and younger patients. Oncotarget 2021;12:1992-2005. [PMID: 34611475 DOI: 10.18632/oncotarget.28082] [Reference Citation Analysis]
255 Yu Y, Chen L, Zhao G, Li H, Guo Q, Zhu S, Li P, Min L, Zhang S. RBBP8/CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer. Oncogene 2020;39:1273-89. [PMID: 31636387 DOI: 10.1038/s41388-019-1060-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
256 El-deiry WS. p21/p53, Cellular Growth Control and Genomic Integrity. In: Vogt PK, Reed SI, editors. Cyclin Dependent Kinase (CDK) Inhibitors. Berlin: Springer Berlin Heidelberg; 1998. pp. 121-37. [DOI: 10.1007/978-3-642-71941-7_6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 52] [Article Influence: 1.0] [Reference Citation Analysis]
257 Sridharan DM, Enerio S, Wang C, Labarge MA, Stampfer MR, Pluth JM. Genetic variation and radiation quality impact cancer promoting cellular phenotypes in response to HZE exposure. Life Sciences in Space Research 2019;20:101-12. [DOI: 10.1016/j.lssr.2018.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
258 Harkin D, Bean JM, Miklos D, Song Y, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA. Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1. Cell 1999;97:575-86. [DOI: 10.1016/s0092-8674(00)80769-2] [Cited by in Crossref: 373] [Cited by in F6Publishing: 127] [Article Influence: 16.2] [Reference Citation Analysis]
259 Coukos G, Conejo-garcia JR, Roden RB, Wu T. Immunotherapy for gynaecological malignancies. Expert Opinion on Biological Therapy 2005;5:1193-210. [DOI: 10.1517/14712598.5.9.1193] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
260 Huang S, Wang LL, Xue NN, Li C, Guo HH, Ren TK, Zhan Y, Li WB, Zhang J, Chen XG, Han YX, Zhang JL, Jiang JD. Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation. Theranostics 2019;9:6745-63. [PMID: 31660066 DOI: 10.7150/thno.34674] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
261 Kavurma MM, Khachigian LM. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation. J Biol Chem. 2003;278:32537-32543. [PMID: 12796485 DOI: 10.1074/jbc.m305650200] [Cited by in Crossref: 58] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
262 Chen X, Arciero CA, Godwin AK. BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. Expert Rev Anticancer Ther 2006;6:187-96. [PMID: 16445371 DOI: 10.1586/14737140.6.2.187] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
263 Olsson A, Manzl C, Strasser A, Villunger A. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ 2007;14:1561-75. [DOI: 10.1038/sj.cdd.4402196] [Cited by in Crossref: 140] [Cited by in F6Publishing: 141] [Article Influence: 9.3] [Reference Citation Analysis]
264 Liu R, Wang L, Chen G, Katoh H, Chen C, Liu Y, Zheng P. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Res 2009;69:2252-9. [PMID: 19276356 DOI: 10.1158/0008-5472.CAN-08-3717] [Cited by in Crossref: 74] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]
265 Desjardins S, Belleau P, Labrie Y, Ouellette G, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Pichette R, Plante M, Durocher F; INHERIT BRCAs. Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families. Int J Cancer 2008;122:108-16. [DOI: 10.1002/ijc.23058] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
266 Xue Q, Liu Z, Feng Z, Xu Y, Zuo W, Wang Q, Gao T, Zeng J, Hu X, Jia F, Zhu Y, Xia Y, Yu L. Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis. Biomedicine & Pharmacotherapy 2020;121:109598. [DOI: 10.1016/j.biopha.2019.109598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
267 Lee E, McKean-Cowdin R, Ma H, Chen Z, Van Den Berg D, Henderson BE, Bernstein L, Ursin G. Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients. Breast Cancer Res 2008;10:R19. [PMID: 18284688 DOI: 10.1186/bcr1865] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
268 Zhong GD, Yu YH. Progress in research of the BRCA1 gene in gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(20): 1939-1944 [DOI: 10.11569/wcjd.v21.i20.1939] [Reference Citation Analysis]
269 Douglass S, Ali S, Meeson AP, Browell D, Kirby JA. The role of FOXP3 in the development and metastatic spread of breast cancer. Cancer Metastasis Rev 2012;31:843-54. [PMID: 22833279 DOI: 10.1007/s10555-012-9395-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
270 Scully R. Role of BRCA gene dysfunction in breast and ovarian cancer predisposition. Breast Cancer Res 2000;2:324-30. [PMID: 11250724 DOI: 10.1186/bcr76] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.3] [Reference Citation Analysis]
271 Xian Ma Y, Fan S, Xiong J, Yuan RQ, Meng Q, Gao M, Goldberg ID, Fuqua SA, Pestell RG, Rosen EM. Role of BRCA1 in heat shock response. Oncogene 2003;22:10-27. [PMID: 12527903 DOI: 10.1038/sj.onc.1206061] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
272 . No stranger to controversy. Nat Genet 1997;17:247-8. [PMID: 9354774 DOI: 10.1038/ng1197-247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
273 Cram EJ, Ramos RA, Wang EC, Cha HH, Nishio Y, Firestone GL. Role of the CCAAT/enhancer binding protein-alpha transcription factor in the glucocorticoid stimulation of p21waf1/cip1 gene promoter activity in growth-arrested rat hepatoma cells. J Biol Chem 1998;273:2008-14. [PMID: 9442037 DOI: 10.1074/jbc.273.4.2008] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 3.8] [Reference Citation Analysis]
274 Koon JC, Kubiseski TJ. Developmental arrest of Caenorhabditis elegans BRAP-2 mutant exposed to oxidative stress is dependent on BRC-1. J Biol Chem 2010;285:13437-43. [PMID: 20207739 DOI: 10.1074/jbc.M110.107011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
275 Cressman VL, Backlund DC, Avrutskaya AV, Leadon SA, Godfrey V, Koller BH. Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol Cell Biol 1999;19:7061-75. [PMID: 10490643 DOI: 10.1128/MCB.19.10.7061] [Cited by in Crossref: 65] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
276 Deng C. Roles of BRCA1 in centrosome duplication. Oncogene 2002;21:6222-7. [DOI: 10.1038/sj.onc.1205713] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 3.5] [Reference Citation Analysis]
277 Lynch J, Keller M, Guo RJ, Yang D, Traber P. Cdx1 inhibits the proliferation of human colon cancer cells by reducing cyclin D1 gene expression. Oncogene. 2003;22:6395-6407. [PMID: 14508520 DOI: 10.1038/sj.onc.1206770] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
278 You F, Chiba N, Ishioka C, Parvin JD. Expression of an amino-terminal BRCA1 deletion mutant causes a dominant growth inhibition in MCF10A cells. Oncogene 2004;23:5792-8. [PMID: 15122325 DOI: 10.1038/sj.onc.1207739] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
279 Lafarge S, Montané MH. Characterization of Arabidopsis thaliana ortholog of the human breast cancer susceptibility gene 1: AtBRCA1, strongly induced by gamma rays. Nucleic Acids Res 2003;31:1148-55. [PMID: 12582233 DOI: 10.1093/nar/gkg202] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 3.3] [Reference Citation Analysis]
280 Murray M, Mullan P, Harkin D. Role played by BRCA1 in transcriptional regulation in response to therapy. Biochemical Society Transactions 2007;35:1342-6. [DOI: 10.1042/bst0351342] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
281 Takaoka M, Miki Y. BRCA1 gene: function and deficiency. Int J Clin Oncol 2018;23:36-44. [PMID: 28884397 DOI: 10.1007/s10147-017-1182-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
282 Coene ED, Hollinshead MS, Waeytens AA, Schelfhout VR, Eechaute WP, Shaw MK, Van Oostveldt PM, Vaux DJ. Phosphorylated BRCA1 is predominantly located in the nucleus and mitochondria. Mol Biol Cell 2005;16:997-1010. [PMID: 15591126 DOI: 10.1091/mbc.e04-10-0895] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
283 Yuli C, Shao N, Rao R, Aysola P, Reddy V, Oprea-llies G, Lee L, Okoli J, Partridge E, Reddy ES. BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers. Oncogene. 2007;26:6031-6037. [PMID: 17384678 DOI: 10.1038/sj.onc.1210420] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
284 Warfel NA, El-Deiry WS. p21WAF1 and tumourigenesis: 20 years after. Curr Opin Oncol. 2013;25:52-58. [PMID: 23159848 DOI: 10.1097/cco.0b013e32835b639e] [Cited by in Crossref: 192] [Cited by in F6Publishing: 121] [Article Influence: 21.3] [Reference Citation Analysis]
285 Bertwistle D, Ashworth A. The pathology of familial breast cancer: How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology? Breast Cancer Res 1999;1:41-7. [PMID: 11250682 DOI: 10.1186/bcr12] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
286 Tian X, Xiao BB, Wu A, Yu L, Zhou J, Wang Y, Wang N, Guan H, Shang ZF. Hydroxylated-graphene quantum dots induce cells senescence in both p53-dependent and -independent manner. Toxicol Res (Camb) 2016;5:1639-48. [PMID: 30090463 DOI: 10.1039/c6tx00209a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
287 De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A 1998;95:8375-80. [PMID: 9653194 DOI: 10.1073/pnas.95.14.8375] [Cited by in Crossref: 273] [Cited by in F6Publishing: 260] [Article Influence: 11.4] [Reference Citation Analysis]
288 Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 2006;34:1416-1426. [PMID: 16522651 DOI: 10.1093/nar/gkl010] [Cited by in Crossref: 314] [Cited by in F6Publishing: 314] [Article Influence: 19.6] [Reference Citation Analysis]
289 Favy DA, Rio P, Maurizis JC, Hizel C, Bignon YJ, Bernard-Gallon DJ. Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines. Biochem Biophys Res Commun 1999;258:284-91. [PMID: 10329379 DOI: 10.1006/bbrc.1999.0602] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
290 Marot D, Opolon P, Brailly-Tabard S, Elie N, Randrianarison V, Connault E, Foray N, Feunteun J, Perricaudet M. The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers. Gene Ther 2006;13:235-44. [PMID: 16208422 DOI: 10.1038/sj.gt.3302637] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
291 Bai F, Smith MD, Chan HL, Pei XH. Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation. Oncogene 2013;32:2715-25. [PMID: 22777348 DOI: 10.1038/onc.2012.293] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
292 Militello AM, Zielli T, Boggiani D, Michiara M, Naldi N, Bortesi B, Zanelli P, Uliana V, Giuliotti S, Musolino A. Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review. Front Oncol 2019;9:759. [PMID: 31456944 DOI: 10.3389/fonc.2019.00759] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
293 Guendel I, Carpio L, Pedati C, Schwartz A, Teal C, Kashanchi F, Kehn-Hall K. Methylation of the tumor suppressor protein, BRCA1, influences its transcriptional cofactor function. PLoS One. 2010;5:e11379. [PMID: 20614009 DOI: 10.1371/journal.pone.0011379] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
294 Culver C, Melvin A, Mudie S, Rocha S. HIF-1α depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs. Cell Cycle 2011;10:1249-60. [PMID: 21412054 DOI: 10.4161/cc.10.8.15326] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
295 Hu YF, Li R. JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction. Genes Dev 2002;16:1509-17. [PMID: 12080089 DOI: 10.1101/gad.995502] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
296 Qiu XB, Lin YL, Thome KC, Pian P, Schlegel BP, Weremowicz S, Parvin JD, Dutta A. An eukaryotic RuvB-like protein (RUVBL1) essential for growth. J Biol Chem 1998;273:27786-93. [PMID: 9774387 DOI: 10.1074/jbc.273.43.27786] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 4.1] [Reference Citation Analysis]
297 Armstrong MJ, Stang MT, Liu Y, Gao J, Ren B, Zuckerbraun BS, Mahidhara RS, Xing Q, Pizzoferrato E, Yim JH. Interferon Regulatory Factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cells. Cancer Lett 2012;319:56-65. [PMID: 22200613 DOI: 10.1016/j.canlet.2011.12.027] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
298 Thangaraju M, Kaufmann SH, Couch FJ. BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J Biol Chem. 2000;275:33487-33496. [PMID: 10938285 DOI: 10.1074/jbc.m005824200] [Cited by in Crossref: 94] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
299 Williams RS, Chasman DI, Hau DD, Hui B, Lau AY, Glover JN. Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations. J Biol Chem 2003;278:53007-16. [PMID: 14534301 DOI: 10.1074/jbc.M310182200] [Cited by in Crossref: 80] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
300 Miyoshi N, Uchida K, Osawa T, Nakamura Y. Selective cytotoxicity of benzyl isothiocyanate in the proliferating fibroblastoid cells. Int J Cancer 2007;120:484-92. [DOI: 10.1002/ijc.22350] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
301 Chen H, Shan J, Chen D, Wang R, Qi W, Wang H, Ke Y, Liu W, Zeng X. CtIP promotes G2/M arrest in etoposide-treated HCT116 cells in a p53-independent manner. J Cell Physiol 2019;234:11871-81. [PMID: 30478995 DOI: 10.1002/jcp.27824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
302 He Y, Brown MA, Rothnagel JA, Saunders NA, Smith R. Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J Cell Sci 2005;118:3173-83. [PMID: 16014382 DOI: 10.1242/jcs.02448] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 5.1] [Reference Citation Analysis]
303 Razandi M, Pedram A, Rosen EM, Levin ER. BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 2004;24:5900-13. [PMID: 15199145 DOI: 10.1128/MCB.24.13.5900-5913.2004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
304 Deng C, Ueda E, Chen KE, Bula C, Norman AW, Luben RA, Walker AM. Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells. Mol Endocrinol 2009;23:226-36. [PMID: 19074549 DOI: 10.1210/me.2008-0075] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
305 Promkan M, Liu G, Patmasiriwat P, Chakrabarty S. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells. Int J Cancer 2009;125:2820-8. [DOI: 10.1002/ijc.24684] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
306 Murtagh J, McArdle E, Gilligan E, Thornton L, Furlong F, Martin F. Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling. J Cell Biol 2004;166:133-43. [PMID: 15226308 DOI: 10.1083/jcb.200403020] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
307 Zhou C, Smith JL, Liu J. Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1. Oncogene 2003;22:2396-404. [DOI: 10.1038/sj.onc.1206319] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 3.0] [Reference Citation Analysis]
308 Fan F, Jin S, Amundson SA, Tong T, Fan W, Zhao H, Zhu X, Mazzacurati L, Li X, Petrik KL, Fornace AJ, Rajasekaran B, Zhan Q. ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene. 2002;21:7488-7496. [PMID: 12386811 DOI: 10.1038/sj.onc.1205896] [Cited by in Crossref: 137] [Cited by in F6Publishing: 132] [Article Influence: 6.9] [Reference Citation Analysis]
309 Venkataramani RN, MacLachlan TK, Chai X, El-Deiry WS, Marmorstein R. Structure-based design of p18INK4c proteins with increased thermodynamic stability and cell cycle inhibitory activity. J Biol Chem 2002;277:48827-33. [PMID: 12370184 DOI: 10.1074/jbc.M208061200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
310 Zheng L, Li S, Boyer TG, Lee W. Lessons learned from BRCA1 and BRCA2. Oncogene 2000;19:6159-75. [DOI: 10.1038/sj.onc.1203968] [Cited by in Crossref: 102] [Cited by in F6Publishing: 98] [Article Influence: 4.6] [Reference Citation Analysis]
311 Ding L, Wang Z, Yan J, Yang X, Liu A, Qiu W, Zhu J, Han J, Zhang H, Lin J, Cheng L, Qin X, Niu C, Yuan B, Wang X, Zhu C, Zhou Y, Li J, Song H, Huang C, Ye Q. Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. J Clin Invest 2009;119:349-61. [PMID: 19139564 DOI: 10.1172/JCI35930] [Cited by in Crossref: 16] [Cited by in F6Publishing: 68] [Article Influence: 1.2] [Reference Citation Analysis]
312 Young JI, Sedivy JM, Smith JR. Telomerase expression in normal human fibroblasts stabilizes DNA 5-methylcytosine transferase I. J Biol Chem 2003;278:19904-8. [PMID: 12665523 DOI: 10.1074/jbc.M301685200] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
313 Hedström E, Issaeva N, Enge M, Selivanova G. Tumor-specific induction of apoptosis by a p53-reactivating compound. Exp Cell Res 2009;315:451-61. [PMID: 19071110 DOI: 10.1016/j.yexcr.2008.11.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
314 Feunteun J. Breast cancer and genetic instability: the molecules behind the scenes. Molecular Medicine Today 1998;4:263-7. [DOI: 10.1016/s1357-4310(98)01262-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
315 MacLachlan TK, Dash BC, Dicker DT, El-Deiry WS. Repression of BRCA1 through a feedback loop involving p53. J Biol Chem 2000;275:31869-75. [PMID: 10884389 DOI: 10.1074/jbc.M003338200] [Cited by in Crossref: 44] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
316 Oishi H, Kitagawa H, Wada O, Takezawa S, Tora L, Kouzu-fujita M, Takada I, Yano T, Yanagisawa J, Kato S. An hGCN5/TRRAP Histone Acetyltransferase Complex Co-activates BRCA1 Transactivation Function through Histone Modification. Journal of Biological Chemistry 2006;281:20-6. [DOI: 10.1074/jbc.m510157200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
317 Haile DT, Parvin JD. Activation of Transcription in Vitro by the BRCA1 Carboxyl-terminal Domain. Journal of Biological Chemistry 1999;274:2113-7. [DOI: 10.1074/jbc.274.4.2113] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 2.7] [Reference Citation Analysis]
318 Bai L, Shi G, Zhang X, Dong W, Zhang L. Transgenic expression of BRCA1 disturbs hematopoietic stem and progenitor cells quiescence and function. Exp Cell Res 2013;319:2739-46. [PMID: 23850973 DOI: 10.1016/j.yexcr.2013.06.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
319 Seth P. Pre-clinical Studies with Tumor Suppressor Genes. In: Habib NA, editor. Cancer Gene Therapy. New York: Springer US; 2002. pp. 183-92. [DOI: 10.1007/0-306-46817-4_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
320 Xu P, Liu Q, Xie Y, Shi X, Li Y, Peng M, Guo H, Sun R, Li J, Hong Y, Liu X, Xu G. Breast cancer susceptibility protein 1 (BRCA1) rescues neurons from cerebral ischemia/reperfusion injury through NRF2-mediated antioxidant pathway. Redox Biol 2018;18:158-72. [PMID: 30014904 DOI: 10.1016/j.redox.2018.06.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
321 Berton TR, Matsumoto T, Page A, Conti CJ, Deng CX, Jorcano JL, Johnson DG. Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues. Oncogene 2003;22:5415-26. [PMID: 12934101 DOI: 10.1038/sj.onc.1206825] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
322 Gudmundsdottir K, Ashworth A. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 2006;25:5864-74. [DOI: 10.1038/sj.onc.1209874] [Cited by in Crossref: 389] [Cited by in F6Publishing: 342] [Article Influence: 24.3] [Reference Citation Analysis]
323 Girgert R, Hanf V, Emons G, Gründker C. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. J Pineal Res 2009;47:23-31. [PMID: 19522736 DOI: 10.1111/j.1600-079X.2009.00684.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
324 Owen GI, Richer JK, Tung L, Takimoto G, Horwitz KB. Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem. 1998;273:10696-10701. [PMID: 9553133 DOI: 10.1074/jbc.273.17.10696] [Cited by in Crossref: 255] [Cited by in F6Publishing: 253] [Article Influence: 10.6] [Reference Citation Analysis]
325 Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:928-942. [PMID: 15234026 DOI: 10.1016/j.ijrobp.2004.03.005] [Cited by in Crossref: 590] [Cited by in F6Publishing: 535] [Article Influence: 32.8] [Reference Citation Analysis]
326 Wiesmüller L. Genetic Stabilization by p53 Involves Growth Regulatory and Repair Pathways. J Biomed Biotechnol 2001;1:7-10. [PMID: 12488620 DOI: 10.1155/S1110724301000043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
327 Lu M, Arrick BA. Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms. Oncogene 2000;19:6351-60. [PMID: 11175350 DOI: 10.1038/sj.onc.1204025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
328 Sheng G, Bernabe KQ, Guo J, Warner BW. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression. Gastroenterology. 2006;131:153-164. [PMID: 16831599 DOI: 10.1053/j.gastro.2006.05.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
329 Maclachlan TK, Somasundaram K, Sgagias M, Shifman Y, Muschel RJ, Cowan KH, El-deiry WS. BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression. Journal of Biological Chemistry 2000;275:2777-85. [DOI: 10.1074/jbc.275.4.2777] [Cited by in Crossref: 143] [Cited by in F6Publishing: 141] [Article Influence: 6.5] [Reference Citation Analysis]
330 Huyton T, Bates PA, Zhang X, Sternberg MJ, Freemont PS. The BRCA1 C-terminal domain: structure and function. Mutation Research/DNA Repair 2000;460:319-32. [DOI: 10.1016/s0921-8777(00)00034-3] [Cited by in Crossref: 92] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
331 Pellikainen MJ, Pekola TT, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis. J Clin Pathol 2003;56:214-20. [PMID: 12610102 DOI: 10.1136/jcp.56.3.214] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
332 March JC, Bentley WE. RNAi-based tuning of cell cycling in Drosophila S2 cells—effects on recombinant protein yield. Appl Microbiol Biotechnol 2007;73:1128-35. [DOI: 10.1007/s00253-006-0560-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
333 Miyake T, Hu YF, Yu DS, Li R. A functional comparison of BRCA1 C-terminal domains in transcription activation and chromatin remodeling. J Biol Chem 2000;275:40169-73. [PMID: 11016938 DOI: 10.1074/jbc.M007138200] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
334 Klopfleisch R, Gruber AD. Differential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adenocarcinomas versus normal mammary glands. Res Vet Sci. 2009;87:91-96. [PMID: 19185891 DOI: 10.1016/j.rvsc.2008.12.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
335 Shin SY, Kim CG, Lim Y, Lee YH. The ETS family transcription factor ELK-1 regulates induction of the cell cycle-regulatory gene p21(Waf1/Cip1) and the BAX gene in sodium arsenite-exposed human keratinocyte HaCaT cells. J Biol Chem 2011;286:26860-72. [PMID: 21642427 DOI: 10.1074/jbc.M110.216721] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
336 MacLachlan TK, Takimoto R, El-Deiry WS. BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol Cell Biol. 2002;22:4280-4292. [PMID: 12024039 DOI: 10.1128/MCB.22.12.4280-4292.2002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
337 Kiick KL, Tirrell DA. Protein Engineering by In Vivo Incorporation of Non-Natural Amino Acids: Control of Incorporation of Methionine Analogues by Methionyl-tRNA Synthetase. Tetrahedron 2000;56:9487-93. [DOI: 10.1016/s0040-4020(00)00833-4] [Cited by in Crossref: 67] [Article Influence: 3.0] [Reference Citation Analysis]
338 Xiao G, Yang Q, Bao Z, Mao H, Zhang Y, Lin S. Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis. BMC Cancer 2020;20:525. [PMID: 32503466 DOI: 10.1186/s12885-020-07014-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
339 Anderson SF, Schlegel BP, Nakajima T, Wolpin ES, Parvin JD. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat Genet 1998;19:254-6. [PMID: 9662397 DOI: 10.1038/930] [Cited by in Crossref: 270] [Cited by in F6Publishing: 272] [Article Influence: 11.3] [Reference Citation Analysis]
340 Gorodetska I, Kozeretska I, Dubrovska A. BRCA Genes: The role in genome stability, cancer stemness and therapy resistance. J Cancer. 2019;10:2109-2127. [PMID: 31205572 DOI: 10.7150/jca.30410] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 14.7] [Reference Citation Analysis]
341 Krum SA, Womack JE, Lane TF. Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activity. Oncogene 2003;22:6032-44. [PMID: 12955082 DOI: 10.1038/sj.onc.1206515] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
342 Marijnen CA, Kapiteijn E, Nagtegaal ID, Mulder-Stapel AA, van de Velde CJ, Schrier PI, Peltenburg LT, van Krieken JH. p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas. Int J Radiat Oncol Biol Phys 2002;52:720-8. [PMID: 11849795 DOI: 10.1016/s0360-3016(01)02674-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
343 Lee JS, Collins KM, Brown AL, Lee CH, Chung JH. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature. 2000;404:201-204. [PMID: 10724175 DOI: 10.1038/35004614] [Cited by in Crossref: 354] [Cited by in F6Publishing: 353] [Article Influence: 16.1] [Reference Citation Analysis]
344 Raderschall E, Bazarov A, Cao J, Lurz R, Smith A, Mann W, Ropers H, Sedivy JM, Golub EI, Fritz E, Haaf T. Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis. Journal of Cell Science 2002;115:153-64. [DOI: 10.1242/jcs.115.1.153] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
345 Prat J, Ribé A, Gallardo A. Hereditary ovarian cancer. Human Pathology 2005;36:861-70. [DOI: 10.1016/j.humpath.2005.06.006] [Cited by in Crossref: 116] [Cited by in F6Publishing: 83] [Article Influence: 6.8] [Reference Citation Analysis]
346 Zajc I, Filipič M, Lah TT. Xanthohumol Induces Different Cytotoxicity and Apoptotic Pathways in Malignant and Normal Astrocytes: XANTHOHUMOLS' EFFECT ON CANCER AND NORMAL ASTROCYTES. Phytother Res 2012;26:1709-13. [DOI: 10.1002/ptr.4636] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
347 Kieback DG, Hasenburg A, Runnebaum IB, Tong XW, Fischer D. Gene Therapy of Ovarian Cancer—State-of-the-Art and Future Perspectives. Diagnosis and Management of Ovarian Disorders. Elsevier; 2003. pp. 277-304. [DOI: 10.1016/b978-012053642-9/50026-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
348 Price M, Monteiro AN. Fine tuning chemotherapy to match BRCA1 status. Biochem Pharmacol 2010;80:647-53. [PMID: 20510205 DOI: 10.1016/j.bcp.2010.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
349 Garcia JM, Rodriguez R, Dominguez G, Silva JM, Provencio M, Silva J, Colmenarejo A, Millan I, Muñoz C, Salas C, Coca S, España P, Bonilla F. Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer. Gut 2003;52:1756-63. [PMID: 14633957 DOI: 10.1136/gut.52.12.1756] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
350 Ting NS, Lee W. The DNA double-strand break response pathway: becoming more BRCAish than ever. DNA Repair 2004;3:935-44. [DOI: 10.1016/j.dnarep.2004.03.026] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
351 Wang Y, Yu J, Zhan Q. BRCA1 regulates caveolin-1 expression and inhibits cell invasiveness. Biochem Biophys Res Commun 2008;370:201-6. [PMID: 18343216 DOI: 10.1016/j.bbrc.2008.03.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
352 Zou T, Rao JN, Liu L, Marasa BS, Keledjian KM, Zhang AH, Xiao L, Bass BL, Wang JY. Polyamine depletion induces nucleophosmin modulating stability and transcriptional activity of p53 in intestinal epithelial cells. Am J Physiol Cell Physiol 2005;289:C686-96. [PMID: 15872011 DOI: 10.1152/ajpcell.00085.2005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
353 Weberpals JI, Clark-Knowles KV, Vanderhyden BC. Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway. J Clin Oncol. 2008;26:3259-3267. [PMID: 18591560 DOI: 10.1200/jco.2007.11.3902] [Cited by in Crossref: 48] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
354 Fan S, Yuan R, Ma YX, Xiong J, Meng Q, Erdos M, Zhao JN, Goldberg ID, Pestell RG, Rosen EM. Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding. Oncogene 2001;20:4827-41. [PMID: 11521194 DOI: 10.1038/sj.onc.1204666] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 1.4] [Reference Citation Analysis]
355 Romeo F, Falbo L, Di Sanzo M, Misaggi R, Faniello MC, Viglietto G, Cuda G, Costanzo F, Quaresima B. BRCA1 is required for hMLH1 stabilization following doxorubicin-induced DNA damage. Int J Biochem Cell Biol 2011;43:1754-63. [PMID: 21864706 DOI: 10.1016/j.biocel.2011.08.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
356 Hong C, Kim HA, Firestone GL, Bjeldanes LF. 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 2002;23:1297-305. [PMID: 12151347 DOI: 10.1093/carcin/23.8.1297] [Cited by in Crossref: 138] [Cited by in F6Publishing: 123] [Article Influence: 6.9] [Reference Citation Analysis]
357 Arizti P, Fang L, Park I, Yin Y, Solomon E, Ouchi T, Aaronson SA, Lee SW. Tumor suppressor p53 is required to modulate BRCA1 expression. Mol Cell Biol. 2000;20:7450-7459. [PMID: 11003642 DOI: 10.1128/MCB.20.20.7450-7459.2000] [Cited by in Crossref: 52] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
358 Kannouche P, Angulo J. Overexpression of kin17 protein disrupts nuclear morphology and inhibits the growth of mammalian cells. Journal of Cell Science 1999;112:3215-24. [DOI: 10.1242/jcs.112.19.3215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
359 Schmider A, Gee C, Friedmann W, Lukas JJ, Press MF, Lichtenegger W, Reles A. p21 (WAF1/CIP1) Protein Expression Is Associated with Prolonged Survival but Not with p53 Expression in Epithelial Ovarian Carcinoma. Gynecologic Oncology 2000;77:237-42. [DOI: 10.1006/gyno.2000.5748] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
360 Suen T, Goss PE. Identification of a novel transcriptional repressor element located in the first intron of the human BRCA1 gene. Oncogene 2001;20:440-50. [DOI: 10.1038/sj.onc.1204078] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
361 Chen CJ, Sugiyama K, Kubo H, Huang C, Makino S. Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase. J Virol 2004;78:10410-9. [PMID: 15367607 DOI: 10.1128/JVI.78.19.10410-10419.2004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
362 Fuchsová B, Novák P, Kafková J, Hozák P. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies. J Cell Biol. 2002;158:463-473. [PMID: 12163469 DOI: 10.1083/jcb.200202035] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
363 Li S, Chen PL, Subramanian T, Chinnadurai G, Tomlinson G, Osborne CK, Sharp ZD, Lee WH. Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J Biol Chem 1999;274:11334-8. [PMID: 10196224 DOI: 10.1074/jbc.274.16.11334] [Cited by in Crossref: 130] [Cited by in F6Publishing: 140] [Article Influence: 5.7] [Reference Citation Analysis]
364 Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET. BRCA1-associated growth arrest is RB-dependent. Proc Natl Acad Sci U S A 1999;96:11866-71. [PMID: 10518542 DOI: 10.1073/pnas.96.21.11866] [Cited by in Crossref: 88] [Cited by in F6Publishing: 102] [Article Influence: 3.8] [Reference Citation Analysis]
365 Chai YL, Cui J, Shao N, Shyam E, Reddy P, Rao VN. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter. Oncogene 1999;18:263-8. [PMID: 9926942 DOI: 10.1038/sj.onc.1202323] [Cited by in Crossref: 99] [Cited by in F6Publishing: 123] [Article Influence: 4.3] [Reference Citation Analysis]
366 Tokarz P, Kaarniranta K, Blasiak J. Role of the Cell Cycle Re-Initiation in DNA Damage Response of Post-Mitotic Cells and Its Implication in the Pathogenesis of Neurodegenerative Diseases. Rejuvenation Research 2016;19:131-9. [DOI: 10.1089/rej.2015.1717] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
367 Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR, Kraft AS, Yang VW. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem. 2000;275:18391-18398. [PMID: 10749849 DOI: 10.1074/jbc.c000062200] [Cited by in Crossref: 235] [Cited by in F6Publishing: 138] [Article Influence: 10.7] [Reference Citation Analysis]
368 Chen KE, Walker AM. Prolactin inhibits a major tumor-suppressive function of wild type BRCA1. Cancer Letters 2016;375:293-302. [DOI: 10.1016/j.canlet.2016.03.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
369 Andrews HN, Mullan PB, McWilliams S, Sebelova S, Quinn JE, Gilmore PM, McCabe N, Pace A, Koller B, Johnston PG, Haber DA, Harkin DP. BRCA1 regulates the interferon gamma-mediated apoptotic response. J Biol Chem 2002;277:26225-32. [PMID: 12011077 DOI: 10.1074/jbc.M201316200] [Cited by in Crossref: 49] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
370 Walczak H, Haas TL. Biochemical Analysis of the Native TRAIL Death-Inducing Signaling Complex. In: Mor G, Alvero AB, editors. Apoptosis and Cancer. Totowa: Humana Press; 2008. pp. 221-39. [DOI: 10.1007/978-1-59745-339-4_16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 25] [Article Influence: 0.7] [Reference Citation Analysis]
371 Venkatachalam S, Donehower LA. Murine tumor suppressor models. Mutat Res 1998;400:391-407. [PMID: 9685699 DOI: 10.1016/s0027-5107(98)00018-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
372 Jeffy BD, Chirnomas RB, Romagnolo DF. Epigenetics of breast cancer: Polycyclic aromatic hydrocarbons as risk factors. Environ Mol Mutagen 2002;39:235-44. [DOI: 10.1002/em.10051] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
373 Madison DL, Lundblad JR. C-terminal binding protein and poly(ADP)ribose polymerase 1 contribute to repression of the p21(waf1/cip1) promoter. Oncogene 2010;29:6027-39. [PMID: 20711239 DOI: 10.1038/onc.2010.338] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]